foscarnet has been researched along with ganciclovir in 606 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (3.30) | 18.7374 |
1990's | 329 (54.29) | 18.2507 |
2000's | 147 (24.26) | 29.6817 |
2010's | 94 (15.51) | 24.3611 |
2020's | 16 (2.64) | 2.80 |
Authors | Studies |
---|---|
Breitenbach, JM; Devivar, RV; Drach, JC; Kawashima, E; Kreske, ED; Revankar, GR; Townsend, LB | 1 |
Drach, JC; Townsend, LB; Zou, R | 2 |
Chamberlain, SD; Drach, JC; Girardet, JL; Koszalka, GW; Migawa, MT; Townsend, LB; Walker, JA | 1 |
Chen, JJ; Drach, JC; Townsend, LB; Wei, Y | 1 |
Choi, WJ; Chun, MW; Hong, JH; Jeong, LS; Kim, HO; Lee, CK; Moon, HR; Yoo, SJ | 1 |
Andrei, G; Balzarini, J; De Clercq, E; McGuigan, C; Pathirana, RN; Snoeck, R | 1 |
Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S | 1 |
Brideau, RJ; Cudahy, MM; Homa, FL; Hopkins, TA; Knechtel, ML; Oien, NL; Pitts, TW; Poorman, RA; Schnute, ME; Wathen, MW; Wieber, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Chou, S; Rawlinson, WD; Scott, GM; Weinberg, A | 1 |
Anderson, DJ; Brideau, RJ; Ciske, FL; Collier, SA; Cudahy, MM; Eggen, M; Genin, MJ; Hopkins, TA; Judge, TM; Kim, EJ; Knechtel, ML; Nair, SK; Nieman, JA; Oien, NL; Schnute, ME; Scott, A; Tanis, SP; Vaillancourt, VA; Wathen, MW; Wieber, JL | 1 |
Black, DH; Eberle, R; Focher, F; Gambino, JJ; Lossani, A; Maioli, A; Medveczky, M; Medveczky, P; Shugar, D; Spadari, S; Verri, A; Wright, GE | 1 |
Brideau, RJ; DiPaolo, BA; Hageman, MJ; Hopkins, TA; Knechtel, ML; Larsen, SD; Manninen, PR; Oien, NL; Rohrer, DC; Rush, BD; Schwende, FJ; Stefanski, KJ; Wathen, MW; Wieber, JL; Wilkinson, KF; Zamora, KM; Zhang, Z | 1 |
Chou, S; Li, S; Marousek, GI; Van Wechel, LC; Weinberg, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Brideau, RJ; Collier, SA; Cudahy, MM; Hopkins, TA; Knechtel, ML; Oien, NL; Sackett, RS; Schnute, ME; Scott, A; Stephan, ML; Wathen, MW; Wieber, JL | 1 |
Andrei, G; Balzarini, J; Camarasa, MJ; de Castro, S; Naesens, L; Peromingo, MT; Snoeck, R; Velázquez, S | 1 |
Hamprecht, K; Schott, H; Schott, S; Schott, TC; Schwendener, RA | 1 |
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
Andrei, G; Balzarini, J; Camarasa, MJ; De Castro, S; García-Aparicio, C; Snoeck, R; Velázquez, S | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Daily, SL; Frederick, SL; Harden, EA; Hartline, CB; Jefferson, G; Kern, ER; Maddry, JA; Prichard, MN; Quenelle, DC; Secrist, JA; Tiwari, KN; Whitley, RJ | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Hopkins, TA; Knechtel, ML; Moon, MW; Oien, NL; Parker, TT; Perrault, WR; Stephanski, KJ; Strohbach, JW; Tanis, SP; Thaisrivongs, S; Wathen, MW; Wieber, JL | 1 |
Chen, K; Heasley, SE; Hopkins, TA; Knechtel, ML; Nair, SK; Nieman, JA; Nugent, RA; Oien, NL; Schultz, BL; Stephanski, KJ; Wathen, MW; Wieber, JL; Zerth, HM | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hirsch, MS | 1 |
Heinemann, MH | 1 |
Jacobson, MA | 5 |
Jabs, DA | 4 |
Butler, KM; De Smet, MD; Husson, RN; Jarosinski, P; Lovato, G; Manjunath, K; Montrella, K; Mueller, B; Nussenblatt, RB; Pizzo, PA | 1 |
Salit, IE | 1 |
Evans, JK; Miller, RF; Scoular, A | 1 |
Drew, WL | 4 |
Cerrina, J; Le Roy Ladurie, F | 1 |
Wilson, RJ | 1 |
Skolnik, PR | 1 |
Deray, G; Jacobs, C; Katlama, C | 1 |
Bachman, DM | 1 |
Peters, M; Pohle, HD; Ruf, B; Schürmann, D; Timm, U | 1 |
Polis, MA | 1 |
Balfour, HH; Drew, WL; Hardy, WD; Heinemann, MH; Polsky, B | 1 |
Jacobson, PA; Levinson, ML | 1 |
Gazzard, BG; Harman, C; Mathalone, B; Mitchell, S; Moyle, G | 1 |
Lurain, NS; Tatarowicz, WA; Thompson, KD | 1 |
Reusser, P | 3 |
Spratt, PM | 1 |
Crapotta, J; Freeman, WR; Keefe, KS; Listhaus, AD; Peterson, TJ; Quiceno, JI; Wiley, CA | 1 |
Bachman, DM; Bruni, LM; DiGioia, RA; Harris, PJ; McMackin, CM; Pistole, MC; Thomas, RM; Ward, DJ | 1 |
Lauchart, W | 1 |
Geier, SA; Goebel, FD; Klauss, V; Kronawitter, U; Matuschke, A | 1 |
Dugel, PU; Klatt, EC; Lee, M; Morinelli, EN; Rao, NA | 1 |
Fabricius, EM; Popescu, M; Schmitz, K | 1 |
Morris, DJ | 2 |
Wood, CA | 1 |
de Gans, J; Enting, R; Jansen, C; Portegies, P; Reiss, P | 1 |
Peters, M; Pohle, HD; Ruf, B; Schürmann, D; Timm, H | 1 |
Crumpacker, CS | 1 |
Cox, SW; Wahren, B | 1 |
Leport, C; Longuet, P | 1 |
Drew, WL; Feinberg, J; Jacobson, MA; Miner, RD; O'Donnell, JJ; Parenti, D; Whitmore, PV | 1 |
Petersen, EA | 1 |
Reed, EC | 1 |
Charpentier, B | 1 |
Ash, RC; Carrigan, DR; Drobyski, WR; Knox, KK | 1 |
Marwick, C | 1 |
Degré, M | 1 |
Bruun, JN; Moeland, A | 1 |
Borysiewicz, LK; Gray, JJ; Higenbottam, TW; Scott, JP; Sharples, LD; Smyth, RL; Stewart, S; Wallwork, J; Wreghitt, TG | 1 |
Minor, JR | 1 |
Anderson, S; Beck, EJ; Coker, R; Coleman, D; Harris, JR; Main, J; Migdal, C; Peters, BS; Pinching, AJ | 1 |
Bacchetti, P; Harb, GE; Jacobson, MA | 1 |
Gaballo, A; Gerna, G; Milanesi, G; Parea, M; Percivalle, E; Zavattoni, M; Zipeto, D | 1 |
Gümbel, H; Helm, EB; Ohrloff, C; Schalnus, R | 1 |
De Clercq, E; Himpens, B; Neyts, J; Schols, D; Snoeck, R | 1 |
Jenkins, RE; Peters, BS; Pinching, AJ | 1 |
Carrigan, DR; Drobyski, WR; Knox, KK | 1 |
Barter, G; Gazzard, BG; Hawkins, D; Nelson, MR | 1 |
Coker, RJ; Harris, JR; Horner, P; Migdal, C; Tomlinson, D | 1 |
Griffiths, PD | 1 |
Jacobson, MA; O'Donnell, JJ | 2 |
Henderly, DE; Jampol, LM | 1 |
Bakker-Woudenberg, IA; Lokerse, AF; ten Kate, M | 1 |
Goldberg, DJ; Green, ST; Kennedy, DH; Mack, DJ; Nathwani, D | 1 |
Leport, C; Salmon, D | 1 |
Lane, HC; Manischewitz, JF; Quinnan, GV; Wittek, AE | 1 |
Charles, SJ; Gray, JJ | 1 |
Ellis, MN; Hackman, RC; Ljungman, P; Meyers, JD; Shepp, DH | 1 |
Balzarini, J; Bron, D; De Clercq, E; Delforge, A; Lagneaux, L; Snoeck, R; Stryckmans, P; Van der Auwera, P | 1 |
Meyers, JD; Reed, EC | 1 |
Bryson, YJ | 1 |
Azuma, M; Sakuma, T | 1 |
Chiba, S | 1 |
Pinching, AJ | 1 |
Fraser-Smith, EB; Freitas, VR; Matthews, TR | 1 |
Agut, H; Collandre, H; Huraux, JM; Montagnier, L | 1 |
Acheson, JF; Bradbeer, C; Shah, SM; Spalton, DJ; Thin, RN | 1 |
Brunette, EN; DeBruin, M; Debs, RJ; Montgomery, AB; Shanley, JD | 1 |
Jacobson, MA; Mills, J | 1 |
Meyers, JD | 1 |
Gonzales, MF; Greco, C; Jacobson, MA; Miller, RG; Mills, J; O'Donnell, JJ; Rush, J | 1 |
Bloom, JN; Palestine, AG | 1 |
Girard, PM; Le Hoang, P; Michon, C; Ngovan, P; Simonpoli, AM | 1 |
Ablashi, DV; Fullen, J; Hellman, K; Hung, CL; Salahuddin, SZ; Saxinger, C; Streicher, HZ | 1 |
Coen, DM; Fleming, HE; Leslie, LK; Retondo, MJ | 1 |
Clarke, JR; Davis, JM; Jeffries, DJ; Tyms, AS | 1 |
Bombail, D; Cavazzana, M; De Castro, H; Gluckman, E; Huart, JJ; Jolivet, I; Keable, H; Meletis, J; Nebout, T | 1 |
Cheriyan, UO; Galloway, KS; Ogilvie, KK; Smith, KO | 1 |
Luckie, AP | 1 |
Bryson, HM; Wagstaff, AJ | 1 |
Arevalo, JF; Bergeron-Lynn, G; Capparelli, EV; Connor, JD; Freeman, WR; Gambertoglio, J; Garcia, RF; Gonzalez, C; Kirsch, LS; Quiceno, JI | 1 |
Ai, E; Irvine, AR; Kuppermann, BD; Luckie, AP; Margolis, TP; McCann, JD; Schwartz, DM; Wong, MG | 1 |
Holida, MD; Kook, H; Lee, NF; Peters, C; Rumelhart, SL; Trigg, ME | 1 |
Benhamou, Y; Blanshard, C; Dohin, E; Gazzard, BG; Katlama, C; Lernestedt, JO | 1 |
Costagliola, D; Mary-Krause, M | 1 |
Fernandez-Viladrich, P; Ferrer, I; Gudiol, F; Perez, JL; Podzamczer, D; Reñe, R; Salazar, A; Santin, M | 1 |
Engstrom, RE; Holland, GN | 1 |
Thimons, JJ | 1 |
Aweeka, FT; Emrick, L; Gambertoglio, JG; Jacobson, MA; Jayewardene, A; Kramer, F; Lizak, P; Polsky, B; Tong, W; van der Horst, C | 1 |
Masur, H; Polis, MA | 1 |
Apuzzo, L; Charache, P; Dunn, JP; Forman, MS; Jabs, DA; MacCumber, MW | 1 |
Grob, R; Roedel, C; Ruef, C | 1 |
Barnett, BB; Holy, A; Reist, EJ; Sidwell, RW; Smee, DF | 1 |
Baldanti, F; Gerna, G; Percivalle, E; Revello, MG; Sarasini, A; Zavattoni, M | 1 |
Raffi, F | 1 |
el Amrani, M; Girard, PM; Gozlan, J; Jacomet, C; Lebrette, MG; Monfort, L; Rozenbaum, W | 1 |
Cardineau, E; Freymuth, F; Hurault de Ligny, B; Le Goff, C; Lobbedez, T; Ryckelynck, JP | 1 |
Gayowski, T; Singh, N | 1 |
Decker, CF; Martin, GJ; Murray, DF; Tarver, JH | 1 |
Balfour, HH | 1 |
Irvine, AR | 1 |
Schwartz, DA; Straub, RF; Wilcox, CM | 1 |
Chu, SY; Hanson, DL; Jaffe, HW; Jones, JL; Ward, JW | 1 |
Colucciello, M | 1 |
Gazzard, BG; Moyle, G | 1 |
Brincat, S; Catovsky, D; Iveson, T; Jameson, B; Mehta, J; Paul, B; Powles, R; Singhal, S; Treleaven, J; Zomas, A | 1 |
Bacigalupo, A; Frassoni, F; Gualandi, F; Longren, M; Moro, F; Occhini, D; Sanna, MA; Tedone, E; Trespi, G; van Lint, MT | 1 |
Hamprecht, K; Jahn, G | 1 |
Nadler, PI; Nokta, M; Pollard, RB; Tolpin, MD | 1 |
Assuerus, V; Baudrimont, M; Duvivier, C; el Amrani, M; Gonzales-Canali, G; Gozlan, J; Jacomet, C; Ropert, A; Roullet, E; Saïd, G | 1 |
Boeckh, M; Bowden, R; Goodrich, JM | 1 |
Bols, K; Colebunders, R; Fleerackers, Y; Lachenal, M; Van Damme, L; Van den Abbeele, K | 1 |
Causey, D; Cheung, TW; Davis, R; Feinberg, JE; Heath-Chiozzi, ME; Jacobson, MA; Murphy, RL; Owens, S; Power, M; Wulfsohn, M | 1 |
Bassiakos, Y; Geheb, H; Hooton, T; Jacobson, MA; Korvick, JA; Kramer, F; O'Donnell, JJ; Polsky, B; van der Horst, C; Walker, JD | 1 |
Andersson, B; Deisseroth, AB; Giralt, S; Goodrich, J; Ippoliti, C; Luna, M; Mehra, R; Panina, A; Przepiorka, D; van Besien, K | 1 |
Decazes, JM; Karmochkine, M; Lagrange, P; Modai, J; Molina, JM; Morinet, F; Schnell, L; Scieux, C; Welker, Y | 1 |
Fujino, Y; Kimura, S; Mochizuki, M; Mouri, H; Nagata, Y; Oka, S; Ono, A; Shimada, K | 1 |
Dieterich, DT; McMeeking, AA; Poles, MA; Scholes, JV | 1 |
Mehta, J; Powles, R; Singhal, S | 1 |
Freeman, WR | 2 |
Charlebois, E; Harb, G; Jacobson, MA; Stanley, HD | 1 |
Baudouin, C; Berthe, P; Garraffo, R; Hofmann, P; Lapalus, P; Taburet, AM | 1 |
Bogner, JR; Geier, SA; Goebel, FD; Klauss, V; Sadri, I; Schmidt-Kittler, H | 1 |
Alain, S; Mazeron, MC; Morinet, F; Pépin, JM; Raskine, L; Sanson-Le Pors, MJ | 1 |
Dieterich, DT; Lew, EA; Poles, MA | 1 |
Ahmed, T; Cook, P; Mittelman, A; Razis, E | 1 |
Bergmann, F; Grünewald, T; Peters, M; Pohle, HD; Ruf, B; Schürmann, D; Timm, H | 1 |
Berman, SM; Kim, RC | 1 |
Murphy, R; Naughton, K; Weinberg, DV | 1 |
Biron, P; Bosi, A; Cahn, JY; Goldstone, AH; Gorin, NC; Link, H; Ljungman, P; Messina, C; Michallet, M; Richard, C | 1 |
Flores-Aguilar, M; Freeman, WR; Kuppermann, BD; Quiceno, JI; Rickman, LS | 1 |
Brun-Vezinet, F; Leport, C; Levy, S; Pepin, JM; Perronne, C; Puget, S; Vildé, JL | 1 |
Fisher, EJ; Nussbaum, JJ; Roarty, JD | 1 |
Behette, M; Berry, C; Freeman, WR; Friedberg, DN; Fullerton, SC; Munguia, D; Quiceno, JI | 1 |
Collins, P | 1 |
Zaia, JA | 2 |
Cohn, D; De Veranez, D; Kemmerly, S; Phan, LD; Plotkin, B; Safrin, S; Smith, T; Weissbach, N | 1 |
Spaide, RF | 1 |
Bogner, JR; Geier, SA; Goebel, FD; Sadri, I | 1 |
Daon, F; Eugene-Ruelland, G; Freymuth, F; Galateau, F; Petitjean, J | 1 |
Freifeld, AG | 1 |
Cello, JP | 1 |
Jansen, CL; Smit, WM; Surachno, JS; vd Horn, GJ; Wagemans, MA | 1 |
Greenspan, D; Greenspan, JS; Heinic, GS | 1 |
Rubin, RH; Snydman, DR; Werner, BG | 1 |
Baird, BF; Davey, RT; deSmet, MD; Falloon, J; Kovacs, JA; Masur, H; Mellow, S; Nussenblatt, RB; Palestine, AG; Polis, MA | 1 |
Sacks, SL; Sasadeusz, JJ | 1 |
Ash, RC; Burd, EM; Carrigan, DR; Drobyski, WR; Dunne, WM; Flomenberg, N; Horowitz, MM; Knox, KK | 1 |
Dicker, M; Dieterich, DT; Lew, E; Poles, MA; Tepper, R | 1 |
Addessi, A; Dieterich, DT; Friedberg, DN; Holbrook, JT; Lew, EA; Mendez, PE; Murphy, R; Naughton, K; Poles, MA | 1 |
Beijnen, JH; Burger, DM; Keijer, WJ; Koks, CH; Meenhorst, PL; Neuteboom, GH; Vrooland, JL | 1 |
Brockmeyer, NH; Gooss, M; Hengge, UR; Malessa, R; Mertins, L; Steinmetz, R | 1 |
Krom, RA; Marin, E; Paya, CV; Porayko, MK; Steers, JL; Wiesner, RH | 1 |
Capparelli, EV; Connor, JD; Dankner, WM; Flores-Aguilar, M; Fullerton, S; Gambertoglio, JG; Kuppermann, BD; Quiceno, JI; Sherwood, CH; Wolf, DG | 1 |
Cheng, YC; Egan, W; Grill, S; Yao, GQ | 1 |
Young, LH | 1 |
Chenot, JF; Cinatl, J; Doerr, HW; Encke, A; Gümbel, HO; Rabenau, H; Scholz, M; Weber, B | 1 |
Baldanti, F; Barbi, M; Brerra, R; Furione, M; Gerna, G; Percivalle, E; Sarasini, A | 1 |
Flury, R; Giezendanner, S; Meyenberger, C; Weber, R; Wirth, HP; Zala, G | 1 |
Anderson, KP; Azad, RF; Brown-Driver, V; Buckheit, RW | 1 |
Huengsberg, M; Stevenson, M | 1 |
Cohen, BA | 1 |
Baldanti, F; Biron, KK; Chou, S; Gerna, G; Sarasini, A; Silini, E; Stanat, SC; Underwood, MR | 1 |
Detels, R; Glesby, MJ; Graham, NM; Ho, M; Hoover, DR; Phair, JP; Saah, AJ; Weng, S | 1 |
Desatnik, HR; Foster, RE; Lowder, CY | 1 |
Bressler, N; Charache, P; Dunn, JP; Enger, C; Forman, M; Jabs, DA | 1 |
Detels, RR; Hoover, DR; Peng, Y; Phair, JP; Rinaldo, CR; Saah, A; Semba, R | 1 |
Coleson, LC; Holbrook, J; Jabs, DA; Wu, AW | 1 |
Avery, RK; Dodds, EM; Foster, RE; Lowder, CY; Prayson, RA | 1 |
Ljungman, P | 1 |
Mahmood, W; Sacks, SL | 1 |
Baldanti, F; Barbi, M; Biron, KK; Gerna, G; Lazzarin, A; Sarasini, A; Silini, E | 1 |
Balzarini, J; De Clercq, E; Dvoráková, H; Holý, A; Naesens, L; Reymen, D | 1 |
López-Cortés, LF; Pachón-Díaz, J | 1 |
Goedert, JJ; Humphrey, RW; Newcomb, FM; Nishihara, H; O'Brien, TR; Ramos, GA; Saville, MW; Straus, SE; Wyvill, KM; Yarchoan, R | 1 |
Pollard, RB | 1 |
Aschan, J; Ehrnst, A; Klaesson, S; Lewensohn-Fuchs, I; Ljungman, P; Lönnqvist, B; Loré, K; Ringdén, O; Winiarski, J | 1 |
Civitico, G; Locarnini, S; Shaw, T | 1 |
Flaherty, JF | 1 |
Hardy, D | 1 |
Cordonnier, C; Einsele, H; Engelhard, D; Link, D; Ljungman, P; Locasciulli, A; Reusser, P | 1 |
Ai, E; Luckie, AP | 1 |
Danner, SA | 1 |
Bacigalupo, A; Bregante, S; Gualandi, F; Isaza, A; Lamparelli, T; Marmont, AM; Occhini, D; Tedone, E; Trespi, G; Van Lint, MT | 1 |
Chatterjee, S; Lakeman, F; Nii, S; Whitley, RJ; Yamada, M; Yoshida, M | 1 |
Alain, S; Mazeron, MC | 1 |
Larkin, M | 1 |
Bate, K; Brown, G; Colman, P; Conn, J; Street, A | 1 |
Chong, LP; Marx, JL; Patel, SS; Rao, NA; Rutzen, AR; Thach, AB | 1 |
Chin, SY; Khoobehi, B; Peyman, GA; Rahimy, MH; Yang, D | 1 |
Gazzard, B; Halai, R; Mocroft, A; Morcinek, J; Phillips, AN; Youle, M | 1 |
Craigen, JL; Grundy, JE | 1 |
Epps, CH; Rana, SN; Sanders, RJ; Sastry, SM; Walton, RC | 1 |
Bacigalupo, A; Bregante, S; Gualandi, F; Isaza, A; Lamparelli, T; Marmont, AM; Moro, F; Occhini, D; Tedone, E; Trespi, G; Van Lint, MT | 1 |
Eddleston, M; Juniper, M; Peacock, S; Warrell, DA | 1 |
Baruzzo, S; Gotti, E; Moioli, F; Perani, V; Remuzzi, G; Suter, F | 1 |
Courpotin, C; Dollfus, C; Khouri, J; Lasfargues, G; Leverger, G; Maout, F; Quartier, P; Tabone, MD | 1 |
Katz, A; Martin, DF; Spaide, RF; Teich, SA; Toth, I | 1 |
Itin, PH; Lautenschlager, S | 1 |
Breton, G; Crémieux, AC | 1 |
Grose, C | 1 |
Bright, DC | 1 |
Benner, KG; Chou, S; Flora, KD; Olyaei, A; Orloff, SL; Rabkin, JM; Rosen, HR | 1 |
Lyon, AT; Weinberg, DV | 1 |
Friedberg, DN | 1 |
Hardy, WD | 1 |
Kuppermann, BD | 1 |
Fujisaki, T; Gondo, H; Matsuo, I; Minamishima, Y; Minematsu, T; Niho, Y; Otsuka, T; Takenaka, K; Tanimoto, K; Uchida, N | 1 |
Lewis, LL; Mueller, BU; Nussenblatt, RB; Pizzo, PA; Walton, RC; Whitcup, SM | 1 |
Adán, A; Alecrim-Andrade, J; Buira, E; Gatell, JM; Gómez-Sirvent, JL; Guelar, A; Lonća, M; Mallolas, J; Miró, JM; Morales, M; Soriano, E; Zamora, L | 1 |
Baldanti, F; Gerna, G; Percivalle, E; Revello, MG; Sarasini, A; Zella, D | 1 |
Cunningham, ET | 1 |
Gazzard, BG; Moore, DA; Nelson, MR | 1 |
Chiodo, F; Coronado, OV; Manfredi, R; Mastroianni, A | 1 |
Balfour, HH; Boivin, G; Chou, S; Erice, A; Gil-Roda, C; Hanson, MN; Pérez, JL; Sannerud, KJ | 1 |
Berger, BB; Fowell, SM; Jampol, LM; Kumar, S; Loose, IA; Minturn, JT; Moorthy, RS; Rao, NA; Teich, SA; Weinberg, DV | 1 |
Gabriel, V; Herbort, CP; Hirschel, B; Olmari, M; Opravil, M; Sansonetti, A; Stalder, N; Sudre, P; von Overbeck, J | 1 |
Chuang, EL; Freeman, WR; Friedberg, DN; Haidt, SJ; Heinemann, MH; Hurwitz, S; Jabs, DA; Jacobson, MA; Kaplan, HJ; Mueller, AJ | 1 |
Ganem, D; Kedes, DH | 1 |
Gane, EJ; Macartney, M; Portmann, B; Williams, R | 1 |
Drew, WL; Flood, J; Follansbee, S; Garvey, J; Jekic-McMullen, D; Kolberg, J; Miner, R; Poscher, M; Shen, LP | 1 |
Fischer, H; Kapelari, K; McIntosh, K; Sailer, M; Zaknun, D; Zangerle, R | 1 |
Speyrer, MP | 1 |
Chou, S; Drew, WL; Follansbee, SE; Guentzel, S; Lalezari, JP; Marousek, G; Miner, RC; Poscher, ME | 1 |
Biondo, FX; Kaplan, MH; Lipson, SM; Shepp, DH; Soni, M; Sun, T | 1 |
Cline, JJ; Garrett, AD | 1 |
Chiodo, F; Coronado, OV; Dal Monte, P; Lazzarotto, T; Manfredi, R; Mastroianni, A; Spezzacatena, P | 1 |
Horvath, E; Lund, T; Medveczky, MM; Medveczky, PG | 1 |
Katlama, C | 1 |
Andersson, B; Champlin, R; Gajewski, J; Giralt, S; Ippoliti, C; Khouri, I; Mehra, R; Morgan, A; Przepiorka, D; van Besien, K; Warkentin, D | 1 |
Pérez, JL | 1 |
Ericzon, BG; Hägglund, H; Ringdén, O; Sparrelid, E; Winiarski, J | 1 |
Fujimori, Y; Kakishita, E; Kanamaru, A; Mori, A; Okada, M; Okamoto, T; Saheki, K; Takatsuka, H; Takemoto, Y; Tamura, A; Wada, H | 1 |
Hampl, W; Hartmann, A; Mertens, T; Michel, D; Pavić, I; Schleyer, I; Zimmermann, A | 1 |
Méndez Marín, I; Montero, M; Pérez-Blázquez, E; Traspas, R | 1 |
Lalezari, JP | 1 |
Einsele, H; Hebart, H; Jahn, G; Kanz, L | 1 |
Takahashi, K | 1 |
Usui, M; Usui, N | 1 |
Okada, S; Tanaka-Taya, K | 1 |
Cinatl, J; Guembel, HO; Hofmann, F; Makabe, R; van Even, G | 1 |
Smith, CL | 1 |
Baldanti, F; Biron, KK; Gerna, G | 1 |
Pau, AK | 1 |
Cunningham, ET; Jones, MR; Schwartz, D; Silverstein, BE; Smith, JH; Sykes, SO | 1 |
Anders, HJ; Bogner, JR; Goebel, FD; Weiss, N | 1 |
Goodgame, RW | 1 |
Bianchi Porro, G; Parente, F | 1 |
Cinque, P; Cleator, GM; Gerna, G; Klapper, PE; Monteyne, P; Sindic, C; van Loon, AM; Weber, T | 1 |
Andreu, D; Arnó, A; Bonjoch, A; Clotet, B; Conejero, M; Jou, A; Romeu, J; Ruiz, L; Ruiz, S; Sirera, G; Tural, C | 1 |
Ciulla, TA; Duker, JS; Morley, MG; Rutledge, BK | 1 |
Behnsch, M; Bergmann, F; Grobusch, MP; Liekfeld, A; Schürmann, D | 1 |
Chevallier, M; Dumortier, J; Durupt, S; Trépo, C; Zoulim, F | 1 |
Benson, CA; Deutsch, TA; Dieterich, DT; Drew, WL; Feinberg, J; Friedberg, DN; Griffiths, PD; Hardy, WD; Holland, GN; Jabs, DA; Jacobson, MA; Kessler, HA; Polis, MA; Powderly, WG; Spector, SA; Walmsley, S; Whitley, RJ | 1 |
Althaus, C; Hudde, T; Loeffler, KU; Schimkat, M; Sundmacher, R | 1 |
Cherrington, JM; Cihlar, T; Fuller, MD | 1 |
Agut, H; Challine-Lehmann, D; Gautheret-Dejean, A; Kirch, C; Rieux, C; Vernant, JP | 1 |
Font, RL; Girard, B; Hauw, JJ; Park, SS; Young, LH | 1 |
Derbolav, A; Krepler, K; Mühlbauer, B; Rieger, A; Ries, E; Ruhswurm, I; Svolba, G; Wedrich, A | 1 |
Cinatl, J; Scholz, M; Vogel, JU | 1 |
Chou, S; Drew, WL; Gordon, SM; LaVoy, AG; Marousek, G; Miner, RC; Parenti, DM; Ross, JG | 1 |
Baldanti, F; Furione, M; Gerna, G; Percivalle, E; Revello, MG; Sarasini, A; Torsellini, M; Zavattoni, M | 1 |
Cassetti, LI; Espinoza, L; Hansman-Whiteman, ML; Jayaweera, DT; Lopardo, GD; Scerpella, EG | 1 |
Bacigalupo, A; Berisso, G; Bregante, S; Bruno, B; Gualandi, F; Lamparelli, T; Mordini, N; Moretti, S; Occhini, D; Tedone, E; Van Lint, MT; Zikos, P | 1 |
Dunn, JP; Enger, C; Forman, M; Hubbard, L; Jabs, DA | 1 |
Hamprecht, K; Jahn, G; Maierl, J; Prix, L | 1 |
Baldanti, F; Gerna, G; Percivalle, E; Revello, MG | 1 |
Freeman, WR; Garcia, CR; Torriani, FJ | 1 |
Cherrington, JM; Drew, WL; Fuller, MD; Lalezari, JP; Lamy, PD; Miner, R; Nuessle, S | 1 |
Kijlstra, A; Paydafar, D; ten Kate, FJ; van den Horn, GJ; van der Meer, JT; Verbraak, FD; Wertheim-van Dillen, PM | 1 |
Bergeron, MG; Boivin, G; Gaudreau, A; Handfield, J; Lalonde, R; Murray, G; Routy, JP; Toma, E | 1 |
Gee, L; Jacobson, MA; Lugo, D; Robles, R | 1 |
Fuchs, AV; Jäger, H; Kampik, A; Scheider, A; Wolf, E | 1 |
Apperley, JF; Baccarani, M; Fanin, R; Stocchi, R; Ward, KN | 1 |
Cheung, TW; Teich, SA | 1 |
Flores-Aguilar, M | 1 |
Bergeron, MG; Boivin, G; Handfield, J; Lalonde, R; Toma, E | 1 |
Champlin, R; Giralt, S; Hecht, D; Ippoliti, C; Jacobson, K; Luna, M; Nguyen, Q; Raad, I; Rolston, K; Tarrand, J; Whimbey, E | 1 |
Skiest, DJ | 1 |
Cai, GY; Chou, S; Crumpacker, CS; Lurain, NS; Sharma, PL; Weinberg, A | 1 |
Huang, J; Rabkin, CS; Testa, MA; Von Roenn, JH | 1 |
Drew, WL; Lalezari, JP | 1 |
Tseng, A; Walmsley, S | 1 |
de la Iglesia, JL; Iglesias, J; Lambert, JL; Manso, JV; Oña, M | 1 |
Hoy, J | 1 |
Clark, AD; Geretti, AM; Griffiths, PD; Johnston, RE; Potter, M; Prentice, HG; Wheeler, AC | 1 |
Keating, MR | 1 |
Au Eong, KG; Beatty, S; Charles, SJ | 1 |
Aversa, F; Ballanti, S; Barozzi, P; Gurdo, G; Luppi, M; Tabilio, A; Tiacci, E; Torelli, G | 1 |
Blaheta, RA; Cinatl, J; Doerr, HW; Gümbel, HO; Kotchetkov, R; Scholz, M; Vogel, JU; Weimer, E | 1 |
Biron, K; Brambilla, D; Britt, W; Chou, S; Crumpacker, C; Drew, WL; Erice, A; Gilliam, B; Jokela, J; Landry, ML; Lurain, N; Manischewitz, J; Miner, R; Nokta, M; Reichelderfer, P; Spector, S; Stanat, S; Weinberg, A; Yen-Lieberman, B | 1 |
Emery, VC | 2 |
Bareta, J; Hidalgo, J; Rhee, W; Steidl, S; Wutoh, AK | 1 |
Delfraissy, JF; Frau, E; Furlan, V; Goujard, C; Labetoulle, M; Lantz, O; Lecointe, D; Niessen, F; Offret, H; Rogier, H | 1 |
Andrei, G; De Clercq, E; Myhren, F; Neyts, J; Sandvold, ML; Snoeck, R | 1 |
Durand, H; Gisselbrecht, M; Haas, C; Lowenstein, W; Marteau, P; Roudière, L | 1 |
Anduze-Faris, BM; Boukli, N; Caumes, E; Costagliola, D; Fillet, AM; Gasnault, J; Gozlan, J; Katlama, C; Lancar, R; Leport, C; Livartowsky, J; Matheron, S; Salmon, D | 1 |
Agut, H; Debré, P; Gautheret-Dejean, A; Grenot, P; Huraux, JM; Manichanh, C | 1 |
Fong, IW; Fong, MW; Ho, J; Lo, B; Toy, C | 1 |
Bini, EJ; Gorelick, SM; Weinshel, EH | 1 |
Einsele, H; Hebart, H | 1 |
Bacigalupo, A; Benvenuto, F; Berisso, G; Bertilson, S; Bregante, S; Figari, O; Gualandi, F; Lamparelli, T; Mordini, N; Raiola, AM; Tedone, E; Trespi, G; Van Lint, MT | 1 |
Boeckh, M; Corey, L; Davis, CL; Koelle, DM; Limaye, AP | 1 |
Dworkin, MS; Hanson, DL; Jaffe, HW; Jones, JL | 1 |
Davis, MD; Gilpin, AK; Holbrook, JT; Holland, GN; Hubbard, LD; Jabs, DA; Martin, BK; Meinert, C; Reshef, DS | 1 |
Althaus, C; Best, J; Gantke, B; Kersten, A; Theisen, A | 1 |
Brytting, M; Linde, A; Mousavi-Jazi, M; Sundqvist, VA; Wahren, B | 1 |
Eckle, T; Hamprecht, K; Handgretinger, R; Jahn, G; Klingebiel, T; Prix, L; Selle, B | 1 |
Hoffman, VF; Skiest, DJ | 1 |
Chou, S; Drew, WL; Miner, RC | 1 |
Distler, A; Ketteler, M; Mertz, A; Offermann, G; Preuschof, L; Schäfer, H; Stöffler-Meilicke, M | 1 |
Boeckh, M; Corey, L; Davis, C; Drew, WL; Gooley, T; Huang, M; Miner, R; Nichols, WG | 1 |
Bolaños-Meade, J; Buddharaju, LN; Chen, T; Cottler-Fox, M; Cross, A; Fassas, AB; Lovchik, JC; Rapoport, A; Tricot, G | 1 |
Boeckh, M; Chuang, EL; Corey, L; Crippa, F; Sale, G | 1 |
Feinberg, J; Wilkin, A | 1 |
Castagnola, E; Cristina, E; Dallorso, S; Giacchino, R; Lanino, E | 1 |
Fine, HF; Murante, BL; Nussenblatt, RB; Robinson, MR; Smith, JA | 1 |
Chan, CC; Robinson, MR; Roy, CE; Velez, G; Whitcup, SM | 1 |
Claro-Cala, CM; Cordero, E; López-Cortés, LF; Lucero-Muñoz, MJ; Pastor-Ramos, MT; Ruiz-Valderas, R; Uceda-Montañés, A | 1 |
Brugger, W; Einsele, H; Grigoleit, U; Gscheidle, B; Hebart, H; Kanz, L; Loeffler, J; Schäfer, H; Sinzger, C | 1 |
Amjad, M; Carlson, RM; Gillespie, MA; Karim, MR | 1 |
Blanchet, KD | 1 |
Cheng, B | 2 |
Woodward, J | 1 |
Baker, R | 1 |
Bowers, M | 1 |
Smart, T | 2 |
Palestine, AG | 1 |
Mascolini, M | 1 |
Spector, SA | 1 |
Highleyman, L | 1 |
Foster, RE; Neuss, MN; Osher, RH; Petersen, MR | 1 |
Adriaanse, HM; Dekkers, CA; Greijer, AE; Middeldorp, JM; The, TH; van der Bij, W; Verschuuren, EA | 1 |
Lee, TA; Malinverni, R; Pleil, AM; Ramsey, SD; Steger, PJ; Sullivan, SD; Veenstra, DL; Williamson, T | 1 |
Basara, N; Kiehl, MG | 1 |
Castagnola, E; Chierici, M; Cristina, E; Lanino, E; Miano, M; Morreale, G | 1 |
Amo, K; Aono, T; Hara, J; Kim, JY; Matsuda, Y; Miyagawa, H; Ohta, H; Okada, S; Sashihara, J; Sawada, A; Tanaka-Taya, K; Tano, Y; Tokimasa, S; Yamamoto, S; Yamanishi, K | 1 |
Boulad, F; Cihlar, T; George, D; Kiehn, TE; Lin, DC; Polsky, B; Prasad, VK; Regan, A; Seo, SK | 1 |
Brytting, M; Drew, WL; Harmenberg, J; Linde, A; Miner, RC; Mousavi-Jazi, M; Schloss, L; Wahren, B | 1 |
Herrero, M; Labeaga, R; Margall, R; Muñoz, JM; Otegui, M; Prats, G; Rabella, N | 1 |
Battmer, K; Dammann, E; Eder, M; Ganser, A; Hambach, L; Heil, G; Hertenstein, B; Stucki, A | 1 |
Salmon-Ceron, D | 1 |
Numazaki, K | 1 |
Knight, DA; LeClaire, JD; Waldman, WJ | 1 |
Cordonnier, C; Einsele, H; Engelhard, D; Finke, J; Lee, J; Link, H; Ljungman, P; Reusser, P; Rovira, M; Volin, L | 1 |
Brytting, M; Grillner, L; Hökeberg, I; Linde, A; Mousavi-Jazi, M; Schloss, L; Zweygberg-Wirgart, B | 1 |
Cañizares, MA; Casado, JL; González, J; Guerrero, A; Losada, I; Pérez-Elías, MJ; Rubio, R | 1 |
De Clercq, E; Naesens, L | 1 |
Cañete, A; Carvajal, E; Castel, V; Fernández, JM; Verdeguer, A | 1 |
Chou, SW | 1 |
Assi, AC; Lightman, S | 1 |
Fishman, JA; Kallas, WM; Mylonakis, E | 1 |
Williams, IG | 1 |
Davis, JL; Scott, IU; Verm, AM | 1 |
Kimberlin, DW | 1 |
Carrington, D; Cornish, JM; Foot, AB; Goulden, N; Marks, DI; Oakhill, A; Ronghe, MD; Steward, CG | 1 |
Davis, JL; Luu, KM; Scott, IU | 1 |
Baldanti, F; Drach, JC; Gerna, G; Sarasini, A; Zemlicka, J | 1 |
Mitchell, SM; Obi, AA; Zambarakji, HJ | 1 |
Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M | 1 |
Davis, MD; Friedberg, D; Holbrook, JT; Jabs, DA; Lewis, RA; Weinberg, DV | 1 |
Avery, RK; Braun, W; Flechner, SM; Goldman, M; Gordon, SM; Haug, M; Isada, CM; Kohn, D; Long, J; Longworth, DL; Lurain, NS; Maurer, J; Mawhorter, SD; Mossad, SB; Schilz, R; Schmitt, SK; Taege, AJ; Yen-Lieberman, B | 1 |
Balfour, HH; Clark, HB; Holman, CJ; Julin, JE; Krivit, W; van Burik, JH; Webb, C | 1 |
Brytting, M; Mousavi-Jazi, M; Schloss, L; Wahren, B | 1 |
Benz, MS; Davis, JL; Glaser, JS | 1 |
Bidanset, DJ; Kern, ER; Kushner, NL; Long, MC; Williams, SL | 1 |
Bakker, HI; De Boer, FM; Harmsen, MC; Meijer, DK; Molema, G; van der Strate, BW | 1 |
Dickson, J; Gaspar, A; Machado, D; Valdez, O; Weigert, A | 1 |
Boeckh, M; Nichols, WG; Papanicolaou, G; Rubin, R; Wingard, JR; Zaia, J | 1 |
Bodaghi, B; Cassoux, N; Chau Tran, TH; Lehoang, P | 1 |
Andrei, G; Bousseau, A; De Bolle, L; De Clercq, E; Naesens, L; Otto, M; Roy, C; Snoeck, R; Van Lommel, A; Zhang, Y | 1 |
Blanc, C; Gillet, M; Halkic, N; Kovacsovics, T; Ksontini, R; Meylan, P; Mosimann, F; Muheim, C; Scholl, B | 1 |
Eksborg, S | 1 |
Alain, S; Belloc, S; Brouet, JC; Ducancelle, A; Malphettes, M; Mazeron, MC; Petit, F; Sanson Le Pors, MJ; Scieux, C | 1 |
Amooty, G; Brown, VS; Burroughs, AK; Emery, VC; Geretti, AM; Grace, SC; Griffiths, PD; Hainsworth, EG; Hassan-Walker, AF; Mattes, FM; Nebbia, G; Okwuadi, S; Potter, M; Prentice, G; Sabin, C; Sweny, P | 1 |
Clarke, HE; Maggs, DJ | 1 |
Clark, DA; Emery, VC; Fryer, JF; Griffiths, PD | 1 |
Bodaghi, B; Caspers-Velu, L; Gaudric, A; Lehoang, P; Liesnard, C; Rozenberg, F; Stanescu, D; Tran, TH | 1 |
Baldanti, F; Gerna, G; Lurain, N | 1 |
Dewhurst, S | 1 |
Ceci, G; Francavilla, A; Ierardi, E; Luzzi, I; Monno, R; Rendina, M; Rizzo, C; Rizzo, G | 1 |
Alston, B; Asmuth, DM; Aweeka, F; Borucki, MJ; Caliendo, A; Gnann, J; Hirsch, MS; Hubbard, L; Nadler, PI; Nevin, TT; Nokta, M; Owens, S; Pollard, RB; Sattler, F; Spritzler, J; Waterman, K | 1 |
Chou, S; Giller, RH; Li, S; Quinones, R; Shira, JE; Springer, KL; Weinberg, A | 1 |
Klass, CM; Krug, LT; Offermann, MK; Pozharskaya, VP | 1 |
Tanaka-Taya, K | 2 |
Dediulescu, DF; Dediulescu, L | 1 |
Buonfrate, D; Cesaro, S; Cusinato, R; Manzardo, C; Mengoli, C; Messina, C; Palù, G; Tridello, G; Zhou, X | 1 |
Bando, T; Chen, F; Fukuse, T; Hanaoka, N; Hasegawa, S; Wada, H | 1 |
Carmichael, T; Choonara, YE; Danckwerts, MP; Pillay, V | 2 |
Bellaiche, M; Berrebi, D; Cezard, JP; Ghidini, B; Hugot, JP; Mougenot, JF; Munck, A; Peuchmaur, M; Viala, J | 1 |
Bodaghi, B; Cassoux, N; Davis, JL; de Schryver, I; Kestelyn, P; Lehoang, P; Michelson, S; Rozenberg, F | 1 |
Kitajima, N | 1 |
Moriuchi, H; Moriuchi, M | 1 |
Murayama, T | 1 |
Baldelli, F; Belfiori, B; Canovari, B; Francisci, D; Marroni, M; Morosi, S; Stagni, G | 1 |
Chou, S; Drew, WL; Marousek, GI; Miner, RC | 1 |
Cairo, MS; Cooney, E; Della-Lotta, P; Shereck, EB; van de Ven, C | 1 |
Asano, S; Iseki, T; Konuma, T; Ooi, J; Takahashi, S; Takasugi, K; Tojo, A; Tomonari, A; Tsukada, N | 1 |
Kaiser, PK; Lowder, CY; Singh, RP; Ufret-Vincenty, RL | 1 |
Croubels, S; De Backer, P; Garré, B; Nauwynck, H; Neyts, J; Nugent, J; van der Meulen, K | 1 |
Hori, A; Kami, M; Kato, D; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Morinaga, S; Murashige, N; Narimatsu, H; Shibata, T; Taniguchi, S; Wake, A; Yuji, K | 1 |
Grossman, ME; Hinds, G; Husain, S; Hutt, C; Pol-Rodriguez, M; Wanner, M | 1 |
Hori, A; Kami, M; Kanda, Y; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Narimatsu, H; Tanaka, Y; Taniguchi, S; Wake, A; Yuji, K | 1 |
Eizuru, Y | 1 |
Carbonnel, F | 1 |
Bakri, SJ; Eid, AJ; Kijpittayarit, S; Razonable, RR | 1 |
Cervera, C; Cofan, F; Fica, A; Linares, L; Marcos, MA; Moreno, A; Navasa, M; Pérez, N; Pérez-Villa, F; Pumarola, T; Ramírez, J; Ricart, MJ; Soto, G | 1 |
Michaels, MG | 1 |
Iwasenko, JM; Rawlinson, WD; Scott, GM; Ziegler, JB | 1 |
Casper, K; Fasola, C; Heffron, T; Lehneman, J; Rodriguez, J; Smallwood, G; Stieber, A | 1 |
Chou, S; Marousek, GI | 1 |
Hanson, KE; Palmer, SM; Reddy, AJ; Zaas, AK | 1 |
Chamberlain, MC; Chowdhary, S | 1 |
Angarone, M; Ison, MG | 1 |
Chou, S; Li, S; Marousek, G; Weinberg, A | 1 |
de Vries, RD; Duan, R; Osterhaus, AD; Remeijer, L; Verjans, GM | 1 |
Boucher, HW; Torres-Madriz, G | 1 |
Asano-Mori, Y; Chiba, S; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Shiraki, K; Watanabe, T | 1 |
Bhangoo, MS; Blackburn, BG; Caulfield, AK; Montoya, JG; Troy, SB; Yeom, K | 1 |
Járay, J; Péter, A; Telkes, G; Varga, M | 1 |
Kneen, R; Mallewa, M; Riordan, A; Sohal, A; Solomon, T | 1 |
Bunjes, D; Härter, G; Mertens, T; Michel, D; Schreiber, A; Schubert, A | 1 |
de Weerdt, O; Rothova, A | 1 |
Burgos, D; Cabello, M; González Molina, M; Gutiérrez, C; López, V; Siles, J; Sola, E; Vega, E | 1 |
Boeckh, MJ; Pergam, SA; Travi, G; Xie, H | 1 |
Forman, MS; Jabs, DA; Martin, BK | 1 |
Chiou, SH; Liu, SJ; Peng, YJ; Wen, CW | 1 |
Chan-Kai, BT; Chew, EY; Faia, LJ; Forooghian, F; Lauer, AK; Nussenblatt, RB; Sen, HN; Weichel, ED; Witherspoon, SR; Wong, WT; Yeh, S | 1 |
Goldstein, DA; Kesen, MR; Meghpara, B; Sulkowski, G; Tessler, HH | 1 |
Opozda, A; Pietrzyk, JJ; Tomasik, T | 1 |
Azzi, A; Boivin, G; Lin, SX; Martin, M | 1 |
Asakura, M; Atsuta, Y; Etoh, T; Fukuda, T; Hatanaka, K; Ikegame, K; Kanamori, H; Mori, T; Ogawa, H; Sakamaki, H; Suzuki, R; Takami, A; Taniguchi, S; Yoshida, T; Yoshihara, S; Yujiri, T | 1 |
Yoshikawa, T | 1 |
Xia, CS; Zhang, Z | 1 |
Chou, S; Lurain, NS | 1 |
De Keyzer, K; Peeters, P; Van Laecke, S; Vanholder, R | 1 |
Kern, ER; Prichard, MN | 1 |
Baldwin, K | 1 |
Chou, S | 2 |
Chronister, CL; Kaiser, H; Pagani, JM | 1 |
Asberg, A; Hartmann, A; Haug Dorenberg, D; Kristiansen, KI; Leivestad, T; Myhre, HA; Rollag, H | 1 |
Azzi, A; Boivin, G; Gilbert, C; Goyette, N; Lin, SX | 1 |
Agut, H | 1 |
Capobianchi, A; Foà, R; Gentile, G; Girmenia, C; Iori, AP; Mauro, FR; Micozzi, A; Torelli, GF | 1 |
Razonable, RR | 2 |
Bowlin, TL; Chou, S; Marousek, G | 1 |
Fahle, G; Faia, LJ; Flaxel, CJ; Forooghian, F; Lauer, AK; Nussenblatt, RB; Sen, HN; Stout, JT; Weichel, ED; Yeh, S | 1 |
Blaschke, D; Boldt, LH; Haverkamp, W; Huemer, M; Parwani, A; Rolf, S; Wutzler, A | 1 |
Chavala, S; Miller, MB; Moss, HB; Say, E | 1 |
Carmichael, A; Goldsmith, PM; Husain, MM; Middleton, SJ; Zhang, H | 1 |
Bian, JM; Chen, HR; Chen, P; Guo, Z; He, XP; Liu, D; Liu, XD; Lou, JX; Yang, K; Zhang, Y | 1 |
Nakamura, K | 1 |
Dickson, M; Eliadou, E; Ferguson, P; Goossens, L; Stace, NH; Weinkove, R | 1 |
Bacigalupo, A; Boyd, A; Clissold, S; Curtis, J; Slipper, J | 1 |
Cunha-Bang, Cd; Frederiksen, CM; Gustafsson, F; Iversen, M; Kirkby, N; Kjaer, J; Lepri, AC; Lundgren, JD; Rasmussen, A; Sengeløv, H; Sønderholm, M; Sørensen, SS | 1 |
Brichová, M; Dvořák, J; Heissigerová, J; Kalvodová, B; Ríhová, E; Svozílková, P | 1 |
Albini, TA; Flaxel, CJ; Gupta, S; Mandelcorn, E; Suhler, EB; Vemulakonda, GA; Yeh, S | 1 |
Eliott, D; Elner, SG; Goldberg, N; Johnson, MW; Lieberman, RM; Schneider, EW; van Kuijk, FJ | 1 |
Hartline, CB; James, SH; Lanier, ER; Price, NB; Prichard, MN | 1 |
Goumenos, DS; Kalliakmani, P; Koukoulaki, M; Marangos, M; Papachristou, E; Papasotiriou, M; Savvidaki, E | 1 |
Ablashi, DV; Arbuckle, JH; Hu, J; Luka, J; Medveczky, MM; Medveczky, PG; Montoya, JG; Pantry, SN; Peterson, D; Pritchett, JC; Renne, R | 1 |
Ashizawa, M; Ishihara, Y; Kako, S; Kanda, J; Kanda, Y; Kawamura, K; Kikuchi, M; Kimura, S; Machishima, T; Nakasone, H; Nishida, J; Sakamoto, K; Sato, M; Tanihara, A; Terasako-Saito, K; Wada, H; Yamasaki, R; Yamazaki, R | 1 |
Fischer, L; Göhring, K; Hamprecht, K; Jahn, G; Laib Sampaio, K | 1 |
Abdel-Massih, R; Bermudez, C; Bhama, JK; Clancy, CJ; Crespo, MM; Kwak, EJ; Minces, LR; Mitsani, D; Nguyen, MH; Pilewski, JM; Shields, RK; Silveira, FP; Toyoda, Y | 1 |
Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A | 1 |
Arav-Boger, R; Cai, H; Forman, M; He, R; Kapoor, A; Posner, GH; Venkatadri, R | 1 |
Beersma, MF; Boucher, CA; Falkenburg, F; Hoek, RA; Hoogsteden, HC; Jedema, I; Murk, JL; Pas, SD; Schipper, ME; van Bergeijk, H; van den Blink, B; van Hal, PT; Verkaik, NJ | 1 |
Bowlin, TL; Chou, S; Komazin-Meredith, G; Williams, JD | 1 |
Baumal, CR; Tawse, KL | 1 |
Boivin, G; Piret, J | 1 |
Gregg, K; Hakki, M; Kaul, DR | 1 |
Cavanna, L; Immovilli, P; Mordenti, P; Nobili, E; Zaffignani, E | 1 |
Chou, S; Ercolani, RJ; Lefterova, MI; Pinsky, BA; Sahoo, MK; Strasfeld, LM | 1 |
Agut, H; Aït-Arkoub, Z; Autran, B; Boutolleau, D; Burrel, S; Carcelain, G; Conan, F; Deback, C; Gandjbakhch, I; Varnous, S | 1 |
Behr, J; Giessen, C; Jäger, G; Kneidinger, N; Milger, K; Neurohr, C; Nitschko, H; Schramm, R; Striebinger, H; von Wulffen, W | 1 |
Andrei, G; Coen, N; Duraffour, S; Snoeck, R; Topalis, D | 1 |
Moisseiev, J; Rahav, G; Shapira, Y; Shimoni, A; Somech, R; Vishnevskia-Dai, V | 1 |
Boivin, G; Drouot, E; Eckenroth, BE; Götte, M; Goyette, N; Piret, J | 1 |
Biousse, V; Del Rio, C; Schechter, MC; Weissman, HM; Yeh, S | 1 |
Albini, TA; Churgin, D; Davis, JL; Relhan, N | 1 |
Iapadre, G; Lasorella, S; Mareri, A; Maresca, M; Nigro, G; Tambucci, R | 1 |
Akkoç, G; Atıcı, S; Bakır, M; Çeliker, H; Demir, SÖ; Kadayifci, EK; Karaaslan, A; Kazokoğlu, H; Koç, A; Şenay, E; Soysal, A; Yakut, N | 1 |
Alain, S; Andouard, D; Cahen, R; Couvreux, A; Deering, M; Hantz, S; Ligat, G; Mazeron, MC; Pouteil-Noble, C; Viget, N; Yasdanpanah, Y | 1 |
Fujita, H; Hatanaka, K; Higuchi, H; Iwami, D; Morita, K; Ogawa, Y; Oishi, Y; Sasaki, H; Shinohara, N | 1 |
Angarone, M; Flaherty, J; Ison, MG; Penugonda, S; Rubin, J; Stosor, V; Young, PG | 1 |
Chou, S; Ercolani, RJ; Lanier, ER | 1 |
Fischer, L; Göhring, K; Hamprecht, K; Hofmann, J; Imrich, E; Jahn, G; Sampaio, KL | 1 |
Ambrose, T; Butler, A; Carmichael, A; Duncan, S; English, S; Gkrania-Klotsas, E; Louis-Auguste, J; Massey, D; Middleton, S; Russell, N; Rutter, CS; Sharkey, LM; Woodward, JM | 1 |
Alain, S; Delacour, ML; Essig, M; Fleury, H; Garrigue, I; Kaminski, H; Merville, P; Moulinas, R; Recordon-Pinson, P; Rerolle, JP | 1 |
Ahn, KS; Choi, DL; Hong, HL; Kang, GW; Kim, JD; Lee, IH | 1 |
Agut, H; Bonnafous, P; Gautheret-Dejean, A | 1 |
Dirks, J; Fliser, D; Leyking, S; Mihm, J; Rissland, J; Sester, M; Sester, U; Smola, S; Wilkens, H | 1 |
Ambinder, R; Arav-Boger, R; Avery, RK; Forman, M; Kraus, E; Lees, L; Marr, KA; Neofytos, D; Ostrander, D; Shah, P; Shoham, S; Trollinger, B; Valsamakis, A | 1 |
Ablashi, DV; Ogata, M; Ongrádi, J; Stercz, B; Yoshikawa, T | 1 |
Ariza-Heredia, E; Chemaly, RF; Doan, V; El Chaer, F; Jan, A; Mori, N; Oliver, N; Shah, D; Tayar, J; Tverdek, F; Wang, E | 1 |
Boss, JD; Rosenberg, K; Shah, R | 1 |
Bruminhent, J; Rotjanapan, P; Watcharananan, SP | 1 |
Atsuta, Y; Eto, T; Fukuda, T; Hashimoto, H; Ichinohe, T; Ikebe, T; Kanamori, H; Kondo, T; Miyamoto, T; Mori, T; Ogata, M; Ogawa, H; Oshima, K; Takano, K; Ueda, Y; Ueki, T | 1 |
Agrawal, N; Beltran, D; Echenique, IA; Najafian, N; Ramirez-Ruiz, L | 1 |
Fukuda, T; Hiroshima, Y; Hoshi, K; Ichikawa, N; Kobayashi, H; Ogata, M; Satou, T; Sumi, M; Ueki, T | 1 |
Allen, A; Ison, MG; Lacloche, L; Pierce, B; Richardson, CL | 1 |
Corral, Í; Galán, JC; Kawiorski, MM; López-Martínez, MJ; Rodríguez, M; Sainz de la Maza, S | 1 |
Bernal-Blanco, G; Cintra-Cabrera, M; Fernández-Cuenca, F; Gentil-Govantes, MÁ; González-Roncero, FM; Pérez-Valdivia, MÁ; Rocha-Castilla, JL; Suárez-Benjumea, A; Súñer-Poblet, M; Toapanta-Gaibor, NG | 1 |
Baghban, A; Malinis, M | 1 |
Brothers, AW; Englund, JA; Vora, SB; Waghmare, A | 1 |
Meesing, A; Razonable, RR | 1 |
Fukuda, T; Ogata, M; Phan, TL | 1 |
DeVita, AV; Gentry, BG; Markovich, KC; O'Brien, MS; Selleseth, D; Sethna, P | 1 |
Daikoku, T; Hattori, M; Hisano, M; Miura, K; Nawashiro, Y; Sasada, Y; Shiraki, K; Suehiro, M; Takizawa, K; Yamamoto, S | 1 |
Czarnecka, K; Czarnecka, P; Durlik, M; Tronina, O | 1 |
Zerr, DM | 1 |
Sinkó, J | 1 |
Boibieux, A; Burillon, C; Charleux, B; Denis, P; Frobert, E; Hafidi, M; Janin-Manificat, H; Kodjikian, L; Rabilloud, M | 1 |
Al-Aloul, M; Fu, L; Jones, NP; Santhanakrishnan, K; Steeples, LR | 1 |
Abella Ross, J; Al Malki, MM; Chen, J; Dadwal, SS; Dickter, JK; Ito, JI; Kriengkauykiat, J; Mokhtari, S; Nakamura, R; Tegtmeier, B; Yang, D; Zaia, JA | 1 |
Hakki, M | 1 |
Iida, H; Ino, K; Kajiguchi, T; Kasahara, S; Kasai, M; Kohno, A; Kurahashi, S; Kusumoto, S; Miyao, K; Morishita, T; Murata, M; Nishida, T; Ozawa, Y; Sawa, M; Takami, A; Terakura, S | 1 |
Brown, JW; Domingo, W; Johnsrud, JJ; Nguyen, IT | 1 |
Müller, TF; Näf, B; Rho, E; Schachter, T; von Moos, S; Wüthrich, RP | 1 |
Alain, S; Alexander, BD; Avery, RK; Blumberg, EA; Chemaly, RF; Cordonnier, C; Duarte, RF; Florescu, DF; Fournier, M; Kamar, N; Kumar, D; Maertens, J; Marty, FM; Papanicolaou, GA; Silveira, FP; Sundberg, AK; Witzke, O; Wu, J | 1 |
Kuo, PH; Lin, CC; Liu, WD; Wu, UI; Yu, HC | 1 |
Cho, SY; Choi, SM; Jung, JY; Kim, HJ; Kim, M; Lee, DG; Nho, D; Oh, EJ | 1 |
Chen, S; Huang, X; Li, Q; Li, S; Lin, Y; Qin, A; Shen, A; Xia, L; Xiang, AP; Zhang, L | 1 |
Blumberg, EA; Halpern-Cohen, V | 1 |
Lee, HJ; Woo, SJ | 1 |
Demin, MV; Filatov, FP; Tikhomirov, DS; Tupoleva, TA | 1 |
He, Y; Huang, XJ; Liu, KY; Ma, R; Sun, YQ; Wang, Y; Xu, LP; Zhang, XH | 1 |
Kleiboeker, SB | 1 |
150 review(s) available for foscarnet and ganciclovir
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retina; Retinitis | 1992 |
Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet.
Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Cytomegalovirus infection in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Chorioretinitis; Cytomegalovirus Infections; Encephalitis; Foscarnet; Ganciclovir; Gastroenteritis; Humans; Phosphonoacetic Acid; Pneumonia, Viral | 1992 |
[Cytomegalovirus infection in patients after lung transplantation].
Topics: Acyclovir; Antiviral Agents; Blood Transfusion; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Incidence; Lung Transplantation; Phosphonoacetic Acid; Prevalence; Viral Vaccines | 1992 |
Cytomegalovirus retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Meningitis, Viral; Phosphonoacetic Acid | 1992 |
Foscarnet and ganciclovir in the treatment of cytomegalovirus retinitis.
Topics: Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Foscarnet therapy for AIDS-related opportunistic herpesvirus infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpesviridae Infections; HIV Infections; Humans; Opportunistic Infections; Phosphonoacetic Acid | 1992 |
Treatment and prophylaxis of cytomegalovirus disease.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Gastroenteritis; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis | 1992 |
[Clinical aspects and therapy of infection with cytomegalovirus].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Opportunistic Infections; Transplantation Immunology | 1992 |
[Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii pneumonia after liver transplantation].
Topics: Acyclovir; Combined Modality Therapy; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Liver Transplantation; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Pneumonia, Viral; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Mechanism of action of foscarnet against viral polymerases.
Topics: Antiviral Agents; DNA-Directed RNA Polymerases; Drug Interactions; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae; HIV; HIV Reverse Transcriptase; Humans; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Simplexvirus | 1992 |
[Prophylactic treatments of opportunistic infections in acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Opportunistic Infections; Pentamidine; Phosphonoacetic Acid; Pneumonia, Pneumocystis; Sulfadiazine; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Extrapulmonary cytomegalovirus disease in transplant patients.
Topics: Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Heart Transplantation; Heart-Lung Transplantation; Humans; Immunotherapy; Kidney Transplantation; Liver Transplantation; Organ Transplantation; Phosphonoacetic Acid | 1991 |
Treatment of cytomegalovirus pneumonia in transplant patients.
Topics: Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Organ Transplantation; Phosphonoacetic Acid; Pneumonia, Viral | 1991 |
[Cytomegalovirus infections in transplant patients].
Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Incidence; Organ Transplantation; Phosphonoacetic Acid | 1991 |
[Antiviral agents for the systemic treatment of herpesvirus infections].
Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Phosphonoacetic Acid | 1991 |
[Treatment of herpesvirus infections].
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Phosphonoacetic Acid | 1991 |
Advances in the prevention and treatment of cytomegalovirus infection in hospital patients.
Topics: Antibodies, Monoclonal; Antiviral Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Prognosis | 1991 |
Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet.
Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Foscarnet; Ganciclovir; HIV Infections; Humans; Opportunistic Infections; Phosphonoacetic Acid; Retinitis | 1991 |
Diagnosis and treatment of cytomegalovirus retinitis.
Topics: Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Eye Infections, Viral; Foscarnet; Ganciclovir; HIV Infections; Humans; Opportunistic Infections; Phosphonoacetic Acid; Retinitis | 1991 |
Treatment of cytomegalovirus infection.
Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Interferons; Nucleosides; Phosphonoacetic Acid | 1987 |
Promising new antiviral drugs.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Humans; Interferons; Phosphonoacetic Acid; Ribavirin; Thymidine; Zidovudine | 1988 |
Cotton-wool spots and cytomegalovirus retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Infections; Diabetic Retinopathy; Diagnosis, Differential; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Pneumonia, Pneumocystis; Prognosis; Retinal Diseases; Retinitis; Zidovudine | 1989 |
Cytomegalovirus infection in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Addison Disease; Antiviral Agents; Colitis; Cytomegalovirus Infections; Encephalitis; Esophageal Diseases; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis | 1989 |
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Gastroenteritis; Humans; Opportunistic Infections; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis | 1988 |
Management of cytomegalovirus infection.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Phosphonoacetic Acid; Pneumonia, Viral | 1988 |
The diagnosis of cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Opportunistic Infections; Phosphonoacetic Acid; Retinitis; Vision Disorders | 1988 |
[Treatment of cytomegalovirus infections in immunosuppressed patients].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunologic Deficiency Syndromes; Organophosphorus Compounds; Phosphonoacetic Acid | 1988 |
Cytomegalovirus retinitis in patients with AIDS: current status.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans | 1995 |
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpesviridae; HIV; Humans; Immunocompromised Host; Virus Diseases; Virus Replication | 1994 |
Local therapy for cytomegalovirus retinopathy.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents, Local; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Delivery Systems; Drug Implants; Foscarnet; Ganciclovir; Humans; Injections; Vitreous Body | 1995 |
CMV retinitis treatment.
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans | 1995 |
Promising new treatments for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Injections, Intralesional; Organophosphonates; Organophosphorus Compounds | 1995 |
[Cytomegalovirus infections in AIDS].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans | 1995 |
Current management of cytomegalovirus disease in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Randomized Controlled Trials as Topic | 1994 |
Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease.
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence | 1995 |
Strategies for the prevention of cytomegalovirus disease after marrow transplantation.
Topics: Bone Marrow Transplantation; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans | 1994 |
Adverse effects and drug interactions of clinical importance with antiviral drugs.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Didanosine; Drug Interactions; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Vidarabine; Zalcitabine; Zidovudine | 1994 |
Retinal disease associated with AIDS.
Topics: AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Fundus Oculi; Ganciclovir; HIV Infections; Humans; Retinitis | 1993 |
Mechanisms of herpes virus resistance.
Topics: Acyclovir; Animals; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae; Herpesviridae Infections; Humans | 1993 |
Prevention and treatment of cytomegalovirus pneumonia in transplant recipients.
Topics: Acyclovir; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Lung Diseases, Interstitial; Organ Transplantation; Pneumonia; Transplantation | 1993 |
[Cytomegalovirus infection after transplantation. Virological diagnosis, antiviral treatment].
Topics: Antibodies, Viral; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Foscarnet; Ganciclovir; Humans; Organ Transplantation; Polymerase Chain Reaction; Postoperative Complications | 1993 |
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin | 1993 |
Oral CMV lesions and the HIV infected. Early recognition can help prevent morbidity.
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Mouth Diseases; Ulcer | 1993 |
New developments in cytomegalovirus prevention and management.
Topics: Antibodies, Viral; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Immunoglobulins, Intravenous; Immunosuppression Therapy; Kidney Transplantation; Prevalence | 1993 |
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet).
Topics: Acquired Immunodeficiency Syndrome; Cohort Studies; Cytomegalovirus Infections; Didanosine; Drug Tolerance; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Injections, Intravenous; Retinitis; Survival Rate; Time Factors; Zidovudine | 1993 |
Systemic antivirals in herpesvirus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Animals; Antiviral Agents; Clinical Trials as Topic; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Vidarabine | 1993 |
Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Cytomegalovirus Infections; Eye Diseases; Foscarnet; Ganciclovir; Humans; Retinitis | 1993 |
Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation.
Topics: Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Incidence; Liver Transplantation; Risk Factors; Time Factors; Vaccination | 1993 |
Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Randomized Controlled Trials as Topic; United States; Vision, Ocular | 1995 |
Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Infant, Newborn; Neoplasms; Opportunistic Infections; Organ Transplantation; Pneumonia, Viral | 1995 |
Anti-infective therapy for viral pneumonia.
Topics: Acyclovir; Amantadine; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Neuraminidase; Pneumonia, Viral; Ribavirin; Rimantadine | 1995 |
A foveal-sparing pattern of cytomegalovirus retinitis in the acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Foscarnet; Fovea Centralis; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Visual Acuity | 1996 |
Management of cytomegalovirus disease.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Foscarnet; Ganciclovir; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds | 1995 |
[Active antiviral agents against human cytomegalovirus and their use in pediatrics].
Topics: Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Foscarnet; Ganciclovir; Humans; Infant | 1996 |
Current management of cytomegalovirus retinitis in AIDS update on ganciclovir and foscarnet for CMV infections.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans | 1996 |
Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae; Herpesviridae Infections; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine | 1996 |
Severe cytomegalovirus infection in immunocompetent patients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Cytomegalovirus Infections; Diagnosis, Differential; Fatal Outcome; Female; Foscarnet; Ganciclovir; Humans; Immunocompetence; Liver; Lung; Male; Middle Aged | 1997 |
Viral lesions of the mouth in HIV-infected patients.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cytomegalovirus Infections; Disease Progression; Famciclovir; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Leukoplakia, Hairy; Lymphoma, B-Cell; Lymphoma, T-Cell; Molluscum Contagiosum; Mouth Diseases; Mouth Neoplasms; Oral Ulcer; Prodrugs; Sarcoma, Kaposi; Stomatitis, Herpetic; Tumor Virus Infections; Valacyclovir; Valine; Virus Diseases; Warts | 1997 |
[Treatment of cytomegalovirus infections in HIV infection].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans | 1996 |
Childhood infections with human herpesviruses types 6, 7, and 8.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Antiviral Agents; Burkitt Lymphoma; Central Nervous System; Child; Child, Preschool; Exanthema Subitum; Foscarnet; Ganciclovir; Genome, Viral; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Herpesvirus 8, Human; Humans; Sarcoma, Kaposi; Transplantation | 1996 |
Pharmacologic management of cytomegalovirus retinitis: review of current and future therapeutic modalities.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Male; Visual Acuity | 1997 |
Cytomegalovirus retinitis: diagnosis and status of systemic therapy.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Diagnosis, Differential; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Ophthalmoscopy | 1997 |
Management strategies for patients with cytomegalovirus retinitis.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Interactions; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds | 1997 |
Therapeutic options for resistant cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Organophosphonates; Organophosphorus Compounds; Recurrence; Thionucleotides | 1997 |
Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1997 |
Combination antiviral therapy for cytomegalovirus disease in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans | 1997 |
Management of CMV retinitis in HIV infected patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Organophosphorus Compounds; Prodrugs; Prospective Studies; Recurrence | 1997 |
Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance.
Topics: Antiviral Agents; Cidofovir; Codon; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins; Viral Structural Proteins | 1997 |
New treatment options for CMV retinitis in AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Retinitis | 1997 |
Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Guidelines as Topic; Hematopoietic Stem Cell Transplantation; Humans; Organ Transplantation | 1998 |
[Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Purines; Thymidine Kinase | 1998 |
[Cytomegalovirus retinitis].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Diagnosis, Differential; Foscarnet; Ganciclovir; HIV-1; Humans; Prognosis; Retina | 1998 |
[Human herpesvirus-6 and -7 infection and bone marrow transplantation (BMT)].
Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Bone Marrow Transplantation; Foscarnet; gamma-Globulins; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunocompromised Host; Polymerase Chain Reaction | 1998 |
Local therapy for cytomegalovirus retinitis.
Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Vitreous Body | 1998 |
Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Male; Peripheral Nervous System Diseases; Spinal Nerve Roots; Treatment Outcome | 1998 |
Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Diagnostic Techniques, Neurological; DNA, Viral; Encephalitis, Viral; Foscarnet; Ganciclovir; Humans; Polymerase Chain Reaction; Polyradiculopathy | 1998 |
Treatment of cytomegalovirus diseases.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1997 |
Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised.
Topics: Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Transplantation; Treatment Failure; Viral Load; Viremia | 1998 |
Cidofovir in the treatment of cytomegalovirus (CMV) retinitis.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Injections; Organophosphonates; Organophosphorus Compounds | 1998 |
Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Topics: Acyclovir; Adolescent; Adult; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Hematopoietic Stem Cells; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunotherapy, Adoptive; Infant; Pneumonia, Viral; Risk Factors; Sensitivity and Specificity; T-Lymphocytes, Cytotoxic; Transplantation Conditioning; Transplantation, Homologous; Viral Vaccines; Viremia; Virus Activation | 1999 |
Cytomegalovirus infection in patients with HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1999 |
Clinically resistant cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Fundus Oculi; Ganciclovir; Humans | 1995 |
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
Topics: Antiviral Agents; Biomarkers; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Diagnosis, Differential; Foscarnet; Ganciclovir; Herpesviridae; Humans; Incidence; Organophosphonates; Organophosphorus Compounds; Risk Factors | 1999 |
Cytomegalovirus: disease syndromes and treatment.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System Diseases; Chorioretinitis; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds; Pneumonia; Sexually Transmitted Diseases, Viral | 1999 |
Comparative tolerability of therapies for cytomegalovirus retinitis.
Topics: Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; HIV Infections; Humans | 1999 |
Management of CMV infections in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1999 |
Antiviral agents for non-human immunodeficiency virus infections.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir | 1999 |
Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Retinal Detachment | 1999 |
Cytomegalovirus drug resistance.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Organophosphorus Compounds | 1998 |
Cytomegalovirus infection following stem cell transplantation.
Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Blood Donors; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunocompromised Host; Immunotherapy, Adoptive; Leukocyte Transfusion; Organophosphonates; Organophosphorus Compounds; Premedication; Risk Factors; Tissue Donors; Transfusion Reaction; Virus Latency | 1999 |
Therapeutic developments in cytomegalovirus retinitis.
Topics: Adenine; Antibodies, Monoclonal; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drugs, Investigational; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valganciclovir | 2000 |
Prophylaxis against fungal infections and cytomegalovirus disease after bone marrow transplantation.
Topics: Antifungal Agents; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Mycoses; Opportunistic Infections; Prognosis; Retrospective Studies; Surgical Wound Infection | 2000 |
Progress in understanding cytomegalovirus drug resistance.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Forecasting; Foscarnet; Ganciclovir; Humans; Incidence; Organophosphonates; Organophosphorus Compounds | 2001 |
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Economics, Pharmaceutical; Foscarnet; Ganciclovir; Humans; Models, Economic; Organophosphonates; Organophosphorus Compounds; Switzerland; Treatment Failure | 2001 |
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Cystitis; Cytarabine; Cytomegalovirus Infections; DNA, Neoplasm; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Prednisolone; Prostaglandins; Remission Induction; Topotecan; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2001 |
Cytomegalovirus infection: the point in 2001.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Monitoring; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Population Surveillance; Predictive Value of Tests; Prevalence; Risk Factors; Valganciclovir | 2001 |
[Cytomegalovirus infection].
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Disease Transmission, Infectious; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prognosis | 2001 |
Recent developments in herpesvirus therapy.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Clinical Trials as Topic; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valacyclovir; Valine | 2001 |
Cytomegalovirus drug resistance and clinical implications.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Incidence; Organ Transplantation; Organophosphonates; Organophosphorus Compounds; Risk Factors | 2001 |
Management of CMV disease in HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Encephalitis, Viral; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds | 1999 |
Prevention and management of CMV-related problems after hematopoietic stem cell transplantation.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Risk Factors | 2002 |
[Drugs against human cytomegalovirus].
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine | 2002 |
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.
Topics: Acyclovir; Antigens, CD34; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunotherapy; Lymphocyte Depletion; Organophosphonates; Organophosphorus Compounds; Transplantation Conditioning | 2003 |
The pharmacokinetics of antiviral therapy in paediatric patients.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Child; Child, Hospitalized; Cidofovir; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Virus Diseases | 2003 |
Clinical characteristics of acute HSV-2 retinal necrosis.
Topics: Acyclovir; Adult; Antiviral Agents; Aqueous Humor; Child; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; Herpes Simplex; Herpesvirus 2, Human; Humans; Interferons; Male; Middle Aged; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Virus Activation; Visual Acuity; Vitreous Body | 2004 |
Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs.
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins; Virus Replication | 2004 |
Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system.
Topics: Antiviral Agents; Central Nervous System Viral Diseases; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Practice Guidelines as Topic; Roseolovirus Infections | 2004 |
Campylobacter fetus bacteremia in an immunocompromised patient: case report and review of the literature.
Topics: Adult; Bacteremia; Campylobacter fetus; Campylobacter Infections; Ciprofloxacin; Cytomegalovirus; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Splenectomy; Steroids | 2004 |
[Human cytomegalovirus infection].
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; gamma-Globulins; Ganciclovir; HIV Infections; Humans; Immunotherapy, Adoptive; Opportunistic Infections; Reverse Transcriptase Inhibitors; Transplantation; Viral Vaccines | 2005 |
[Antiherpetic therapy].
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Bromodeoxyuridine; Cidofovir; Cytosine; Drug Combinations; Famciclovir; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Herpetic; Oligonucleotides; Ophthalmic Solutions; Organophosphonates; Treatment Outcome; Valacyclovir; Valine; Vidarabine | 2005 |
Is combination antiviral therapy for CMV superior to monotherapy?
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Synergism; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
[Therapy for cytomegalovirus infection].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Immunotherapy; Transplantation | 2006 |
[Treatment of HHV-6 and HHV-7 infections].
Topics: Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunoglobulins; Lymphocyte Transfusion; Organophosphonates; Roseolovirus Infections | 2006 |
[Development of drug-resistant human cytomegalovirus].
Topics: Antiviral Agents; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins; Virus Replication | 2006 |
[Human cytomegalovirus infection].
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Globins; Humans; Immunotherapy, Adoptive; Viral Vaccines | 2007 |
[Mechanism of drug-resistance in human cytomegalovirus].
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins | 2007 |
[Management of severe or corticosteroid resistant ulcerative colitis].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antiviral Agents; Colectomy; Colitis, Ulcerative; Cyclosporine; Cytomegalovirus Infections; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Multicenter Studies as Topic; Prospective Studies; Radionuclide Imaging; Randomized Controlled Trials as Topic; Time Factors | 2007 |
Treatment of congenital cytomegalovirus: where are we now?
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Organophosphonates; Pregnancy; Valganciclovir | 2007 |
Prevention and early treatment of opportunistic viral infections in patients with leukemia and allogeneic stem cell transplantation recipients.
Topics: Antiviral Agents; Benzimidazoles; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpes Zoster; Humans; Immune Sera; Immunization, Passive; Immunocompromised Host; Leukemia; Opportunistic Infections; Ribonucleosides; Stem Cell Transplantation; Virus Diseases | 2008 |
Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
Topics: Antiviral Agents; Chemoprevention; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Organ Transplantation; Organophosphonates; Transplantation; Valganciclovir | 2008 |
[Gastrointestinal cytomegalovirus infections in organ transplant patients].
Topics: Acyclovir; Antiviral Agents; Biopsy; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Endoscopy, Gastrointestinal; Foscarnet; Ganciclovir; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Immunocompromised Host; Immunoglobulins; Immunotherapy, Adoptive; Intestinal Mucosa; Organ Transplantation; Organophosphonates; Primary Prevention; Valganciclovir | 2008 |
Antiviral treatment of cytomegalovirus infection and resistant strains.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Thionucleotides; Valganciclovir | 2009 |
[Human herpesvirus 6 encephalitis].
Topics: Antiviral Agents; Double-Blind Method; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Hippocampus; Humans; Immunocompromised Host; Infant; Randomized Controlled Trials as Topic; Roseolovirus Infections; Virus Replication | 2010 |
Antiviral drug resistance of human cytomegalovirus.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genome, Viral; Humans; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Sequence Analysis, DNA | 2010 |
The search for new therapies for human cytomegalovirus infections.
Topics: Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Valganciclovir; Virus Replication | 2011 |
Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections.
Topics: Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Immunity, Cellular; Infant; Organophosphonates; Roseolovirus Infections; Viral Load; Virus Latency | 2011 |
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir | 2011 |
Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.
Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host | 2012 |
[Non-antibiotic anti-infectious treatments in urology].
Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir | 2013 |
Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Isoxazoles; Leflunomide; Lung Transplantation; Middle Aged; Viral Load | 2013 |
Antiviral drug resistance in herpesviruses other than cytomegalovirus.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 3, Human; Herpesvirus 6, Human; Humans; Immunocompromised Host; Organophosphonates | 2014 |
Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Disease Management; Drug Resistance, Viral; Everolimus; Female; Foscarnet; Ganciclovir; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Infant; Male; Middle Aged; Valganciclovir; Viral Load | 2015 |
Bilateral central retinal artery occlusion associated with herpes simplex virus-associated acute retinal necrosis and meningitis: case report and literature review.
Topics: Antibodies, Viral; Antiviral Agents; Aqueous Humor; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Female; Fluorescein Angiography; Foscarnet; Ganciclovir; Herpes Simplex; Herpesvirus 2, Human; Humans; Magnetic Resonance Imaging; Meningitis, Viral; Middle Aged; Polymerase Chain Reaction; Retinal Artery Occlusion; Retinal Necrosis Syndrome, Acute | 2015 |
Anti-viral therapy for congenital cytomegalovirus infection: pharmacokinetics, efficacy and side effects.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Immunocompetence; Organophosphonates; Treatment Outcome | 2016 |
Cytomegalovirus Retinitis in Three Pediatric Cases with Acute Lymphoblastic Leukemia: Case Series and Review of the Literature.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Retinitis; DNA, Viral; Eye; Foscarnet; Ganciclovir; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Valganciclovir; Viremia; Vitreous Body | 2016 |
Human Herpesviruses 6A, 6B, and 7.
Topics: Antiviral Agents; Cidofovir; Cytosine; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunocompromised Host; Organophosphonates; Roseolovirus Infections; Transplant Recipients; Virus Latency | 2016 |
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.
Topics: Adult; Antiviral Agents; Child; Cord Blood Stem Cell Transplantation; Cytokines; Encephalitis, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Immunocompetence; Immunocompromised Host; Limbic Encephalitis; Neuroglia; Risk Factors; Roseolovirus Infections | 2017 |
Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Antiviral Agents; Basiliximab; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Induction Chemotherapy; Kidney Transplantation; Male; Middle Aged; Mutation; Postoperative Complications; Recombinant Fusion Proteins; Tacrolimus; Valganciclovir; Virus Replication | 2018 |
Ganciclovir and foscarnet dual-therapy for cytomegalovirus encephalitis: A case report and review of the literature.
Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Middle Aged; Transplantation, Homologous | 2018 |
New Developments in the Management of Cytomegalovirus Infection After Transplantation.
Topics: Acetates; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Organ Transplantation; Quinazolines; Valganciclovir | 2018 |
Cytomegalovirus Disease After Liver Transplant-A Description of a Treatment-Resistant Case: A Case Report and Literature Review.
Topics: Adult; Antilymphocyte Serum; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Ganciclovir; Graft Rejection; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Risk Factors | 2018 |
Human Herpesvirus 6B in the Transplant Recipient: When to Worry, When to Act.
Topics: Antiviral Agents; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Roseolovirus Infections; Transplant Recipients; Virus Activation | 2018 |
[Current treatment modalities of immunocompromised patients with cytomegalovirus infection. II. Therapeutic options and management strategies].
Topics: Acetates; Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Quinazolines; Stem Cell Transplantation | 2019 |
Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches.
Topics: Antiviral Agents; Cytomegalovirus Retinitis; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leflunomide; Lung Transplantation; Male; Middle Aged; Transplant Recipients | 2020 |
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy.
Topics: Animals; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Vaccines; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Immunotherapy; Immunotherapy, Adoptive; Molecular Targeted Therapy; Opportunistic Infections; Risk Factors; T-Lymphocytes; Treatment Outcome | 2020 |
New Perspectives on Antimicrobial Agents: Maribavir.
Topics: Adult; Anti-Infective Agents; Antiviral Agents; Benzimidazoles; Child; Cidofovir; Cytomegalovirus Infections; Dichlororibofuranosylbenzimidazole; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Valganciclovir | 2022 |
Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Transplant Recipients; Valganciclovir | 2023 |
51 trial(s) available for foscarnet and ganciclovir
Article | Year |
---|---|
The treatment of cytomegalovirus in AIDS--more than meets the eye.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Drug Tolerance; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infections; Drug Administration Schedule; Fluorescein Angiography; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Multicenter Studies as Topic; Opportunistic Infections; Phosphonoacetic Acid; Randomized Controlled Trials as Topic; Retinitis | 1992 |
Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Male; Phosphonoacetic Acid; Retinitis | 1992 |
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Cytomegalovirus Infections; Drug Therapy, Combination; Drug Tolerance; Foscarnet; Ganciclovir; Humans; Leukocyte Count; Phosphonoacetic Acid; Random Allocation; Retinitis; Zidovudine | 1992 |
AIDS file.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1991 |
Foscarnet versus ganciclovir in the management of cytomegalovirus disease in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid | 1991 |
Treatment of cytomegalovirus infection.
Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Interferons; Nucleosides; Phosphonoacetic Acid | 1987 |
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpesviridae; HIV; Humans; Immunocompromised Host; Virus Diseases; Virus Replication | 1994 |
Antiviral effects of foscarnet and ganciclovir therapy on human immunodeficiency virus p24 antigen in patients with AIDS and cytomegalovirus retinitis. Studies of Ocular Complications of AIDS Research Group in collaboration with AIDS Clinical Trials Group
Topics: AIDS-Related Opportunistic Infections; Antigen-Antibody Complex; Cytomegalovirus Retinitis; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Antibodies; HIV Core Protein p24; Homosexuality, Male; Humans; Male; Probability; Risk Factors; Survival Rate; Time Factors | 1995 |
Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison.
Topics: Adult; AIDS-Related Opportunistic Infections; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; Follow-Up Studies; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Middle Aged; Survival Rate; Time Factors | 1995 |
Foscarnet and ganciclovir pharmacokinetics during concomitant or alternating maintenance therapy for AIDS-related cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Administration Schedule; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans | 1995 |
Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
Topics: Acute Kidney Injury; Adolescent; Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Male; Neutropenia; Odds Ratio; Seizures; Water-Electrolyte Imbalance | 1995 |
Foscarnet or ganciclovir for treatment of AIDS and CMV retinitis.
Topics: AIDS-Related Opportunistic Infections; Clinical Trials as Topic; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Treatment Outcome | 1995 |
Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir.
Topics: Adult; Anemia, Aplastic; Antigens, Viral; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulin M; Leukemia; Male; Transplantation, Homologous | 1994 |
Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Salvage Therapy | 1994 |
Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Cells, Cultured; Clinical Protocols; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Retinitis | 1994 |
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Female; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Lymphocyte Subsets; Male; Middle Aged; Photography; Treatment Outcome; Visual Acuity; Visual Fields | 1994 |
Safety of alternating ganciclovir and foscarnet maintenance therapy in human immunodeficiency virus (HIV)-related cytomegalovirus infections. An open-labeled pilot study.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Pilot Projects | 1994 |
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet).
Topics: Acquired Immunodeficiency Syndrome; Cohort Studies; Cytomegalovirus Infections; Didanosine; Drug Tolerance; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Injections, Intravenous; Retinitis; Survival Rate; Time Factors; Zidovudine | 1993 |
Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Male; Middle Aged | 1993 |
Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Male; Morbidity; Quality of Life; Recurrence; Retinitis; Survival Rate; Visual Acuity; Visual Fields | 1996 |
Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Randomized Controlled Trials as Topic; United States; Vision, Ocular | 1995 |
Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bisexuality; Case-Control Studies; Foscarnet; Ganciclovir; Herpesviridae Infections; Homosexuality, Male; Humans; Longitudinal Studies; Male; Risk; Sarcoma, Kaposi | 1996 |
Assessment of cytomegalovirus retinitis. Clinical evaluation vs centralized grading of fundus photographs. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Follow-Up Studies; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Photography; Reproducibility of Results | 1996 |
Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cross-Sectional Studies; Cytomegalovirus Retinitis; Female; Foscarnet; Ganciclovir; Humans; Male; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Vision, Ocular; Visual Acuity | 1996 |
Clinical vs photographic assessment of treatment of cytomegalovirus retinitis. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial Report 8. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Male; Photography; Retina; Treatment Outcome | 1996 |
Design of clinical trials for drug combinations: cytomegalovirus retinitis--foscarnet and ganciclovir. The CMV retinitis retreatment trial.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design | 1996 |
CMV retinitis: ganciclovir/monoclonal antibody.
Topics: Acquired Immunodeficiency Syndrome; Antibodies, Monoclonal; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Viral Envelope Proteins | 1996 |
Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
Topics: Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Incidence; Leukocytes; Polymerase Chain Reaction; Prospective Studies; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Viremia; Virus Activation | 1996 |
Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Disease Progression; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Middle Aged; Proportional Hazards Models; Sarcoma, Kaposi | 1996 |
[Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Administration Schedule; Female; Foscarnet; Ganciclovir; HIV Infections; HIV-1; Humans; Male; Middle Aged; Prospective Studies; Survival Rate | 1997 |
Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance; Foscarnet; Ganciclovir; Humans; Prospective Studies; Retinitis; Treatment Outcome | 1997 |
Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group
Topics: Adolescent; Adult; Age Factors; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Incidence; Infusions, Intravenous; Prospective Studies; Retinal Detachment; Risk Factors; Treatment Outcome; Visual Acuity | 1997 |
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Diseases; Female; Foscarnet; Ganciclovir; Humans; Male; Retinitis; Vision Disorders; Visual Acuity; Visual Fields | 1997 |
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Graft Survival; Humans; Kidney; Male; Middle Aged; Nausea; Transplantation, Homologous; Vomiting | 1997 |
Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
Topics: AIDS-Related Opportunistic Infections; Biopsy; Cytomegalovirus Infections; Esophagitis; Foscarnet; Ganciclovir; Humans; Prospective Studies; Treatment Outcome | 1998 |
[Cytomegalovirus polyradiculomyelopathy in AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Electromyography; Female; Foscarnet; Ganciclovir; Humans; Male; Muscle Tonus; Polyradiculopathy; Spinal Cord Diseases; Treatment Outcome; Urinary Retention | 1998 |
Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Male; Middle Aged; Transplantation, Homologous; Treatment Outcome | 1998 |
Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: incidence and outcome over 2 years.
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; HIV Protease Inhibitors; Humans; Incidence; Indinavir; Nelfinavir; Outcome Assessment, Health Care; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir | 1999 |
Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Drug Tolerance; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Survival Rate | 2000 |
Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study.
Topics: Adult; Antiviral Agents; Blood Pressure; Body Weight; Bone Marrow Transplantation; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Foscarnet; Ganciclovir; Humans; Lymphocyte Depletion; Prospective Studies; Survival Rate; Transplantation, Homologous | 2000 |
Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD8-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Disease Progression; Foscarnet; Ganciclovir; Humans; Lymphocyte Count; Risk Factors; Virus Cultivation | 2000 |
New trial for CMV retinitis.
Topics: Antibodies; Antiviral Agents; Combined Modality Therapy; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Placebos | 1995 |
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Myelodysplastic Syndromes; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Transplantation, Homologous; Treatment Failure; Viremia; Virus Activation | 2001 |
Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Antiviral Agents; Child; Cytomegalovirus Infections; Disease-Free Survival; Drug Administration Schedule; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Thrombocytopenia; Transplantation, Homologous | 2002 |
Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antiretroviral Therapy, Highly Active; Antiviral Agents; Blindness; Cytomegalovirus Retinitis; Female; Foscarnet; Ganciclovir; Humans; Male; Meta-Analysis as Topic; United States; Visual Acuity | 2003 |
A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Viral Load | 2004 |
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus re
Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Double-Blind Method; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Treatment Outcome; Viral Envelope Proteins | 2004 |
A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Humans; Infant; Male; Pilot Projects; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2007 |
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Dichlororibofuranosylbenzimidazole; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Valganciclovir; Viremia | 2022 |
[Clinical analysis of the efficacies of ganciclovir plus foscarnet and a single antiviral drug for the treatment of cytomegalovirus infection after haploidentical stem cell transplantation].
Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies | 2023 |
409 other study(ies) available for foscarnet and ganciclovir
Article | Year |
---|---|
Benzimidazole ribonucleosides: design, synthesis, and antiviral activity of certain 2-(alkylthio)- and 2-(benzylthio)-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazoles.
Topics: Antiviral Agents; Cell Line; Cell Survival; Cytomegalovirus; Dichlororibofuranosylbenzimidazole; Drug Design; Fibroblasts; Herpesvirus 1, Human; Humans; KB Cells; Structure-Activity Relationship | 1994 |
Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
Topics: Antiviral Agents; Benzimidazoles; Cell Division; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Design; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Ribonucleosides; Simplexvirus | 1997 |
Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
Topics: Antiviral Agents; Benzimidazoles; Cell Division; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Design; Humans; KB Cells; Magnetic Resonance Spectroscopy; Molecular Structure; Ribonucleosides; Simplexvirus | 1997 |
Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.
Topics: Antiviral Agents; Benzimidazoles; Cell Division; Cell Survival; Cytomegalovirus; Drug Design; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Herpesvirus 1, Human; Humans; KB Cells; Microbial Sensitivity Tests; Nucleosides; Pentoses; Skin; Stereoisomerism; Structure-Activity Relationship; Viral Plaque Assay | 1998 |
Synthesis and antiviral evaluation of trisubstituted indole N-nucleosides as analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole (TCRB).
Topics: Antiviral Agents; Benzimidazoles; Cell Division; Cell Line; Cytomegalovirus; Enzyme-Linked Immunosorbent Assay; Herpesvirus 1, Human; Herpesvirus 6, Human; Humans; Indoles; Ribonucleosides; Structure-Activity Relationship; Viral Plaque Assay | 2000 |
Syntheses and structure--activity relationships of novel apio and thioapio dideoxydidehydronucleosides as anti-HCMV agents.
Topics: Antiviral Agents; Cell Line; Cytomegalovirus; Dideoxynucleosides; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV-1; Humans; Structure-Activity Relationship | 2001 |
Discovery of a new family of inhibitors of human cytomegalovirus (HCMV) based upon lipophilic alkyl furano pyrimidine dideoxy nucleosides: action via a novel non-nucleosidic mechanism.
Topics: Antiviral Agents; Cell Line; Cytomegalovirus; Furans; Humans; Pyrimidine Nucleosides; Structure-Activity Relationship; Virus Replication | 2004 |
Exploring the role of different drug transport routes in permeability screening.
Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2005 |
4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Nucleic Acid Synthesis Inhibitors; Point Mutation; Pyridines; Pyridones; Structure-Activity Relationship; Thiophenes; Viral Plaque Assay; Viral Proteins | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA Replication; DNA-Directed DNA Polymerase; Drug Resistance, Multiple; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Immunocompromised Host; Mutation; Organophosphonates; Phenotype; Viral Proteins; Virus Replication | 2007 |
2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
Topics: Antiviral Agents; Binding, Competitive; Cytomegalovirus; DNA-Directed DNA Polymerase; Enzyme Inhibitors; Ethylamines; Exodeoxyribonucleases; Herpes Zoster; Herpesviridae; Herpesvirus 1, Human; Herpesvirus 4, Human; Humans; Models, Chemical; Nucleic Acid Synthesis Inhibitors; Pyridines; Structure-Activity Relationship; Viral Proteins | 2007 |
Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.
Topics: Acyclovir; Amino Acid Sequence; Animals; Antiviral Agents; Chlorocebus aethiops; Deoxyuridine; Enzyme Inhibitors; Guanine; Herpesvirus 1, Cercopithecine; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleosides; Phosphorylation; Substrate Specificity; Thymidine; Thymidine Kinase; Vero Cells | 2007 |
7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase.
Topics: Cytomegalovirus; Enzyme Inhibitors; Nucleic Acid Synthesis Inhibitors; Pyridines; Structure-Activity Relationship | 2007 |
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Mutation; Phenotype | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; Cytomegalovirus; Drug Design; Enzyme Inhibitors; Esters; Furans; Herpesviridae; Herpesvirus 3, Human; Herpesvirus 4, Human; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Nucleic Acid Synthesis Inhibitors; Pyridones; Simplexvirus | 2008 |
4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.
Topics: Antiviral Agents; Cell Line; Cytomegalovirus; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Thymidine; Urea | 2008 |
Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
Topics: Antiviral Agents; Cross-Linking Reagents; Cytomegalovirus; Drug Interactions; Foscarnet; Glyceryl Ethers; HIV; Humans; Inhibitory Concentration 50; Simplexvirus; Zidovudine | 2009 |
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |
4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cytomegalovirus; Herpesvirus 3, Human; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Naphthalenesulfonates; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Virus Replication | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
Topics: Animals; Antiviral Agents; Cell Line; Cell Proliferation; Cells, Cultured; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Fluorescent Antibody Technique, Indirect; Herpesviridae; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 6, Human; Herpesvirus 8, Human; Humans; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Structure; Pyrimidine Nucleosides; Viral Proteins; Virus Replication | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase.
Topics: Antiviral Agents; Drug Design; Protease Inhibitors; Quinoxalines; Serine Endopeptidases | 2010 |
Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility.
Topics: Antiviral Agents; Cytomegalovirus; DNA-Directed DNA Polymerase; Herpesviridae; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Nucleic Acid Synthesis Inhibitors; Pyrroles; Quinolines; Solubility; Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Treatment of cytomegalovirus retinitis--1992.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Recurrence; Retinitis | 1992 |
Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus.
Topics: Antiviral Agents; Child, Preschool; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Infections; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Why was treatment of cytomegalovirus retinitis randomized?
Topics: Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Randomized Controlled Trials as Topic; Retinitis | 1992 |
Cytomegalovirus and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis; Retrospective Studies | 1992 |
Treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis; Zidovudine | 1992 |
Treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney; Phosphonoacetic Acid; Retinitis | 1992 |
Treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1992 |
Therapeutic algorithm for treatment of cytomegalovirus retinitis in persons with AIDS. A roundtable summary.
Topics: Acquired Immunodeficiency Syndrome; Adult; Algorithms; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Male; Phosphonoacetic Acid; Retinitis | 1992 |
A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors.
Topics: Antiviral Agents; Chromatography, High Pressure Liquid; Cytomegalovirus; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Foscarnet; Ganciclovir; Humans; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Viral Plaque Assay | 1992 |
Transplantation of the heart and lung.
Topics: Australia; Coronary Artery Disease; Costs and Cost Analysis; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Heart Transplantation; Heart-Lung Transplantation; Humans; Immunosuppression Therapy; Lung Transplantation; Postoperative Complications; Survival Rate; Tissue Donors; Transplantation, Heterotopic | 1992 |
Atypical healing of cytomegalovirus retinitis. Significance of persistent border opacification.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Eye Infections, Viral; Female; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Prospective Studies; Retina; Retinitis; Virus Replication; Wound Healing | 1992 |
Visual field testing in the management of cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Follow-Up Studies; Foscarnet; Fundus Oculi; Ganciclovir; HIV Seropositivity; Humans; Male; Ophthalmoscopy; Photography; Retinitis; Vision Disorders; Visual Field Tests; Visual Fields | 1992 |
2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Cataract Extraction; Cytomegalovirus Infections; Drug Administration Schedule; Drug Tolerance; Eye Infections, Viral; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Recurrence; Retinitis; Survival Rate; Visual Acuity | 1992 |
Opportunistic intraocular infections in AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Choroiditis; Cytomegalovirus Infections; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; HIV-1; Humans; Infant; Male; Middle Aged; Retinitis | 1992 |
[Cytomegalovirus retinitis in AIDS. Effectiveness and complications of long-term therapy].
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Long-Term Care; Recurrence; Retinitis; Retrospective Studies; Visual Acuity; Visual Fields | 1992 |
Treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis; Zidovudine | 1992 |
Foscarnet for CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Function Tests; Phosphonoacetic Acid; Retinitis | 1992 |
Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Meningoencephalitis; Phosphonoacetic Acid | 1992 |
Combined and alternating ganciclovir/foscarnet in HIV-related cytomegalovirus encephalitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Homosexuality; Humans; Male | 1992 |
Treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Zidovudine | 1992 |
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Male; Ophthalmoscopy; Phosphonoacetic Acid; Retinitis | 1991 |
Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation.
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Phosphonoacetic Acid; Pneumonia, Viral | 1991 |
National Eye Institute issues clinical alert about CMV retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Male; Phosphonoacetic Acid; Retinitis | 1991 |
Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment.
Topics: Adolescent; Adult; Antibodies, Viral; Bacterial Infections; Child; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Heart-Lung Transplantation; Humans; Immunization, Passive; Immunosuppression Therapy; Male; Middle Aged; Phosphonoacetic Acid; Pneumonia, Viral; Retrospective Studies; Risk Factors; Tissue Donors; Transfusion Reaction; Virus Diseases | 1991 |
Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Colitis; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; London; Male; Neutropenia; Opportunistic Infections; Phosphonoacetic Acid; Prevalence; Recurrence; Retinitis; Retrospective Studies; Survival Rate; Thrombocytopenia; Zidovudine | 1991 |
Survival of patients with AIDS and cytomegalovirus disease treated with ganciclovir or foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Opportunistic Infections; Phosphonoacetic Acid; Retinitis; Survival Rate | 1991 |
Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Humans; Neutrophils; Phosphonoacetic Acid; Polymerase Chain Reaction; Retinitis; Viral Proteins | 1991 |
[Therapeutic alternative or 2d choice drug. Trisodium phosphonoformate in cytomegalovirus retinitis].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Chorioretinitis; Cytomegalovirus Infections; Drug Therapy, Combination; Fluorescein Angiography; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Opportunistic Infections; Phosphonoacetic Acid | 1991 |
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Esterases; Flow Cytometry; Fluoresceins; Fluorometry; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Polyethylene Glycols; Suramin | 1991 |
Thromboembolic disease in AIDS is associated with cytomegalovirus disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Phosphonoacetic Acid; Thromboembolism | 1991 |
Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient.
Topics: Adult; Antiviral Agents; Bone Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance; Female; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid | 1991 |
Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Male; Phosphonoacetic Acid; Retinitis | 1991 |
Treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
Topics: Adult; Cytomegalovirus Infections; Drug Combinations; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Male; Middle Aged; Phosphonoacetic Acid; Recurrence; Retinitis | 1991 |
Seeing the way forward for treatment of CMV retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infections; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Retinitis | 1991 |
Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes.
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Drug Carriers; Fibroblasts; Foscarnet; Ganciclovir; Humans; Liposomes; Phosphonoacetic Acid; Viral Plaque Assay; Virus Replication | 1990 |
Generalised cutaneous rash associated with foscarnet usage in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Drug Eruptions; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Male; Phosphonoacetic Acid | 1990 |
[Treatment of Cytomegalovirus infection].
Topics: Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Phosphonoacetic Acid | 1990 |
Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro.
Topics: Cytomegalovirus; DNA, Viral; Drug Synergism; Foscarnet; Ganciclovir; Phosphonoacetic Acid; Virus Replication | 1990 |
Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Dendritic; Microbial Sensitivity Tests; Phosphonoacetic Acid; Simplexvirus; Vidarabine | 1990 |
Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.
Topics: Acyclovir; Adult; Animals; Antiviral Agents; Bone Marrow Transplantation; Cells, Cultured; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Herpes Simplex; Humans; Male; Middle Aged; Phosphonoacetic Acid; Pneumonia, Viral; Simplexvirus; Thymidine Kinase; Vero Cells; Vidarabine | 1990 |
Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro.
Topics: Adenine; Adult; Antiviral Agents; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Foscarnet; Ganciclovir; Granulocytes; Hematopoietic Stem Cells; HIV; Humans; Macrophages; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Zidovudine | 1990 |
[Chemotherapy of cytomegalovirus infections].
Topics: Acyclovir; Adenine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid | 1989 |
[Diagnosis and treatment of cytomegalovirus infections].
Topics: Acyclovir; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Phosphonoacetic Acid; Pregnancy; Serologic Tests | 1989 |
Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cytomegalovirus; Dose-Response Relationship, Drug; Drug Synergism; Female; Foscarnet; Ganciclovir; Humans; Mice; Phosphonoacetic Acid; Rats; Simplexvirus; Viral Plaque Assay | 1989 |
Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir.
Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Herpesviridae; Humans; Microbial Sensitivity Tests; Phosphonoacetic Acid | 1989 |
Treatment of CMV retinitis in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Phosphonoacetic Acid; Retina; Retinitis; Visual Acuity | 1987 |
Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus.
Topics: Acyclovir; Administration, Oral; Aerosols; Animals; Antiviral Agents; Cytomegalovirus Infections; Disease Models, Animal; Female; Foscarnet; Ganciclovir; Mice; Mice, Inbred BALB C; Phosphonoacetic Acid; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Ribavirin | 1988 |
Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Encephalomyelitis; Foscarnet; Ganciclovir; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid | 1988 |
In vitro inhibition of human herpesvirus-6 by phosphonoformate.
Topics: Acyclovir; Antiviral Agents; Cell Line; Foscarnet; Ganciclovir; Herpesviridae; Humans; Organophosphorus Compounds; Phosphonoacetic Acid | 1988 |
Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
Topics: Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Idoxuridine; Mutation; Phosphonoacetic Acid; Simplexvirus; Thymidine; Vidarabine | 1985 |
Synthesis of cytomegalovirus DNA is an antiviral target late in virus growth.
Topics: Acyclovir; Antiviral Agents; Cell Line; Cytomegalovirus; DNA, Viral; Floxuridine; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Spermidine; Spermine; Viral Proteins | 1987 |
[Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Phosphonoacetic Acid; Postoperative Complications | 1987 |
Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
Topics: Acyclovir; Antiviral Agents; Cells, Cultured; Drug Synergism; Foscarnet; Ganciclovir; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Viral Plaque Assay | 1982 |
Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Retinal Detachment; Vitreous Body | 1995 |
A sensitive and specific polymerase chain reaction-based assay for the diagnosis of cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Base Sequence; Cytomegalovirus; Cytomegalovirus Retinitis; DNA Primers; DNA, Viral; Drug Therapy, Combination; Eye Diseases; False Positive Reactions; Foscarnet; Ganciclovir; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Sensitivity and Specificity; Vitreous Body; Vitreous Hemorrhage | 1995 |
Cytomegalovirus encephalitis resistant to anti-cytomegalovirus therapy.
Topics: Bone Marrow Transplantation; Child, Preschool; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Drug Resistance; Encephalitis, Viral; Fatal Outcome; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Male; Opportunistic Infections | 1995 |
Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bias; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Information Systems; Male; Proportional Hazards Models; Risk Factors; Sarcoma, Kaposi | 1995 |
Cytomegalovirus ventriculoencephalitis in AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Autopsy; Brain; Cerebral Ventricles; Cerebrospinal Fluid; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Encephalitis, Viral; Foscarnet; Ganciclovir; Humans; Magnetic Resonance Imaging; Male; Tomography, X-Ray Computed; Viremia | 1995 |
Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus; Cytomegalovirus Retinitis; Disease Progression; DNA, Viral; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Viremia | 1995 |
[Clinical value of a polymerase chain reaction on cytomegalovirus DNA in cerebrospinal fluid in HIV patients with neurological symptoms].
Topics: Adult; AIDS Dementia Complex; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Encephalitis, Viral; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polyradiculoneuropathy | 1995 |
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
Topics: Acyclovir; Animals; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Mice; Mice, SCID; Microbial Sensitivity Tests; Muromegalovirus; Nucleosides; Nucleotides; Organophosphonates; Organophosphorus Compounds | 1995 |
Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples.
Topics: Antigens, Viral; Blood; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Viral Plaque Assay | 1995 |
[Lesions of the conus medullaris and the cauda equina caused by cytomegalovirus in HIV infection. 7 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Cauda Equina; Cytomegalovirus Infections; Drug Therapy, Combination; Fatal Outcome; Female; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Middle Aged; Nerve Compression Syndromes; Retrospective Studies; Spinal Nerve Roots | 1995 |
[Quantitative cytomegaloviral leukocytic antigenemia. Clinical aspects].
Topics: Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Leukocytes; Male; Middle Aged; Postoperative Complications | 1995 |
Lack of sustained efficacy of combination ganciclovir and foscarnet for hepatitis B virus recurrence after liver transplantation.
Topics: Drug Therapy, Combination; Foscarnet; Ganciclovir; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; Recurrence | 1995 |
Prolonged concurrent use of ganciclovir and foscarnet in the treatment of polyradiculopathy due to cytomegalovirus in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Peripheral Nervous System Diseases; Spinal Nerve Roots; Time Factors | 1994 |
Intraocular sustained drug release devices.
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Delivery Systems; Eye Infections, Viral; Foscarnet; Ganciclovir; Humans | 1995 |
Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Drug Administration Schedule; Esophagitis; Female; Foscarnet; Ganciclovir; Humans; Male; Probability; Prospective Studies; Recurrence; Survival Analysis; Treatment Outcome | 1995 |
AIDS-associated Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS-Related Opportunistic Infections; Female; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Male; Retrospective Studies; Risk Factors; Sarcoma, Kaposi | 1995 |
Phosphonoformate for CMV retinitis in AIDS.
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Administration Schedule; Foscarnet; Ganciclovir; Humans | 1995 |
Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
Topics: Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hepatitis, Viral, Human; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Meningitis, Listeria; Middle Aged; Opportunistic Infections; Transplantation, Homologous; Viremia | 1994 |
[Cytomegaloviruses--clinical aspects and therapy].
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans | 1994 |
Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication.
Topics: Antibodies, Monoclonal; Antibodies, Viral; Cytomegalovirus; Drug Synergism; Foscarnet; Ganciclovir; Humans; Viral Envelope Proteins; Virus Replication | 1994 |
Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Nervous System Diseases | 1994 |
Two AIDS patients with life-threatening pancreatitis successfully treated, one with ganciclovir the other with foscarnet.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Male; Pancreatitis; Recurrence | 1994 |
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Life Tables; Lymphocyte Depletion; Male; Middle Aged; Neutropenia; Premedication; Proportional Hazards Models; Retrospective Studies; T-Lymphocytes; Treatment Failure; Virus Activation | 1994 |
Combined therapy with ganciclovir and foscarnet for cytomegalovirus polyradiculomyelitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Myelitis; Polyradiculopathy | 1994 |
[Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Male | 1994 |
Actinomyces infection of a cytomegalovirus esophageal ulcer in two patients with acquired immunodeficiency syndrome.
Topics: Actinomycosis; Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Esophageal Cyst; Esophagitis; Foscarnet; Ganciclovir; Humans; Male; Penicillin G | 1994 |
Prevention of cytomegalovirus disease by a short course of preemptive ganciclovir or foscarnet.
Topics: Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans | 1994 |
Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease.
Topics: AIDS-Related Opportunistic Infections; Bacterial Infections; Catheterization, Central Venous; Catheters, Indwelling; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Incidence; Leukocyte Count; Neutrophils | 1994 |
Toxicologic and pharmacokinetic analysis of intravitreal injections of foscarnet, either alone or in combination with ganciclovir.
Topics: Animals; Aqueous Humor; Drug Combinations; Electrophysiology; Electroretinography; Foscarnet; Ganciclovir; Half-Life; Injections; Ophthalmoscopy; Rabbits; Retina; Vitreous Body | 1994 |
Drugs for non-HIV viral infections.
Topics: Acyclovir; Amantadine; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Virus Diseases | 1994 |
[Resistance to virostatic agents in Herpes viruses: mechanism, incidence and clinical significance].
Topics: Acyclovir; Antiviral Agents; Drug Resistance; Foscarnet; Ganciclovir; Herpesviridae; Humans; Immunocompetence; Immunocompromised Host; Phosphorylation | 1994 |
Retinal detachment in patients with acquired immunodeficiency syndrome.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Incidence; Male; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Visual Acuity | 1994 |
Rapid detection of cytomegalovirus strains resistant to ganciclovir through mutations within the gene UL97.
Topics: Base Sequence; Bronchoalveolar Lavage Fluid; Cerebrospinal Fluid; Cytomegalovirus; Cytomegalovirus Infections; DNA Probes; Drug Resistance, Microbial; Fibroblasts; Foscarnet; Ganciclovir; Genes, Viral; Humans; Inactivation, Metabolic; Molecular Sequence Data; Mutation; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Urine; Viral Proteins; Viral Structural Proteins | 1993 |
Predisposition to cytomegalovirus infection of the gastrointestinal tract.
Topics: Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans | 1994 |
Treatment of gancyclovir resistant cytomegalovirus with foscarnet: a report of two cases occurring after bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Resistance; Foscarnet; Ganciclovir; Humans; Male; Middle Aged | 1994 |
The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Cerebral Ventricles; Confusion; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Dementia; Encephalitis; Foscarnet; Ganciclovir; Humans; Male; Sleep Stages; Survival Rate | 1994 |
Combined daily therapy with intravenous ganciclovir and foscarnet for patients with recurrent cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Male; Prognosis; Recurrence | 1994 |
Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Infectious Disease Working Party of the European Group for Bone Marrow Transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cytomegalovirus Infections; Europe; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Incidence; Lung Diseases, Interstitial; Middle Aged; Retrospective Studies; Surveys and Questionnaires; Survival Analysis | 1994 |
Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Male; Middle Aged | 1993 |
Cytomegalovirus resistant to foscarnet: clinicovirologic correlation in a patient with human immunodeficiency virus.
Topics: Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Middle Aged; Recurrence | 1993 |
Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Longitudinal Studies; Male; Middle Aged; Morbidity; Retrospective Studies; Vision Disorders; Visual Acuity | 1993 |
Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Infections; Humans; Incidence; Proportional Hazards Models; Prospective Studies; Retinal Detachment; Risk Factors; Time Factors | 1993 |
Foscarnet-resistant herpes simplex virus infection in patients with AIDS.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpes Genitalis; Herpes Labialis; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Vidarabine | 1994 |
Ganciclovir intraocular device and patient survival.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Delivery Systems; Foscarnet; Ganciclovir; Humans; Survival Rate; Vitreous Body | 1994 |
Ganciclovir intraocular device and patient survival.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Delivery Systems; Foscarnet; Ganciclovir; Humans; Survival Rate; Vitreous Body | 1994 |
Evaluation of AIDS-related diarrhea.
Topics: Adult; Ampulla of Vater; Biopsy; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Chronic Disease; Common Bile Duct Diseases; Cytomegalovirus Infections; Decision Trees; Diarrhea; Enteritis; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Male; Medical History Taking | 1993 |
Acute retinal necrosis in a renal allograft recipient--an unusual manifestation of cytomegalovirus infection.
Topics: Adult; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Male; Retinal Diseases; Retinal Necrosis Syndrome, Acute | 1993 |
Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo.
Topics: Adult; Base Sequence; Bone Marrow; Bone Marrow Transplantation; Cohort Studies; Colony-Forming Units Assay; Fever; Foscarnet; Ganciclovir; Hematopoiesis; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Restriction Mapping; Viremia | 1993 |
Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Infections; Demography; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Middle Aged; Regression Analysis; Retrospective Studies | 1993 |
Foscarnet treatment in various cytomegalovirus infections.
Topics: Acquired Immunodeficiency Syndrome; Colitis; Cytomegalovirus Infections; Eye Infections, Viral; Fissure in Ano; Foscarnet; Ganciclovir; Humans; Male; Retinitis; Stomatitis, Aphthous | 1993 |
Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Eye Infections, Viral; Female; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Microbial Sensitivity Tests; Prospective Studies; Retinitis; Survival Rate; Visual Acuity | 1993 |
Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.
Topics: Acyclovir; Antiviral Agents; Base Sequence; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 4, Human; Microbial Sensitivity Tests; Molecular Sequence Data; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; Organophosphorus Compounds; Time Factors | 1993 |
Therapy for cytomegalovirus retinitis: still no silver lining.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Recurrence | 1996 |
In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate.
Topics: Antigens, Viral; Antiviral Agents; Ascorbic Acid; Cells, Cultured; Cytomegalovirus; Endothelium; Fibroblasts; Foscarnet; Ganciclovir; Humans; Virus Replication | 1995 |
Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Foscarnet; Ganciclovir; Humans; Male; Reverse Transcriptase Inhibitors; Time Factors; Viral Plaque Assay | 1995 |
[Clinical manifestations and course of cytomegalovirus colitis in AIDS patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cohort Studies; Colitis; Colonoscopy; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies | 1995 |
Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs.
Topics: Antiviral Agents; Base Sequence; Cell Line; Cytomegalovirus; Drug Interactions; Foscarnet; Ganciclovir; HIV-1; Humans; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; RNA, Viral; Thionucleotides; Virus Replication; Zalcitabine; Zidovudine | 1995 |
Ganciclovir in cytomegalovirus retinitis.
Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Drug Therapy, Combination; Encephalitis, Viral; Foscarnet; Ganciclovir; Homosexuality, Male; Humans; Male | 1995 |
Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Base Sequence; Cerebrospinal Fluid; Cytomegalovirus; Cytomegalovirus Infections; DNA Primers; Encephalitis; Foscarnet; Ganciclovir; Genes, Immediate-Early; HIV Seropositivity; Humans; Male; Meningitis; Molecular Sequence Data; Polymerase Chain Reaction; Prognosis; Sensitivity and Specificity; Spinal Cord Diseases | 1996 |
Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered f
Topics: AIDS-Related Opportunistic Infections; Amino Acid Sequence; Base Sequence; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Ganciclovir; Humans; Molecular Sequence Data; Mutation; Phenotype; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor) | 1996 |
Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Injections; Male; Recurrence; Vitreous Body | 1996 |
Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Baltimore; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Incidence; Male; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Seroepidemiologic Studies; Urine; Viremia | 1996 |
Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; HIV Infections; HIV-1; Humans; Immune Tolerance; Incidence; Male; Pneumonia, Pneumocystis; Prevalence; Survival Rate; Zidovudine | 1996 |
Serous retinal detachments in a patient with clinically resistant cytomegalovirus retinitis.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Exudates and Transudates; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Male; Recurrence; Retinal Detachment; Visual Acuity | 1996 |
Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir- and foscarnet-specific resistance, respectively.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Ganciclovir; Genes, Viral; Humans; Mutation; Polymerase Chain Reaction; Viral Envelope Proteins | 1995 |
Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
Topics: Adenine; Antiviral Agents; Cell Line; Cidofovir; Cytopathogenic Effect, Viral; Cytosine; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Nucleosides; Organophosphonates; Organophosphorus Compounds | 1995 |
Treatment of cytomegalovirus retinitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Routes; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Retinitis | 1996 |
New developments in the treatment of CMV retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Injections; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Vitreous Body | 1996 |
[Current status of the management of cytomegalovirus retinitis in patients with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans | 1996 |
Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Base Sequence; Blood Coagulation Disorders; Cohort Studies; DNA, Viral; Female; Foscarnet; Ganciclovir; Herpesviridae; Herpesviridae Infections; HIV Seronegativity; Homosexuality; Humans; Leukocytes, Mononuclear; Male; Molecular Sequence Data; Prevalence; Risk Factors; Sarcoma, Kaposi; Skin Neoplasms | 1996 |
Interaction between ganciclovir and foscarnet as inhibitors of duck hepatitis B virus replication in vitro.
Topics: Animals; Antiviral Agents; Cells, Cultured; DNA Replication; DNA, Viral; Drug Combinations; Ducks; Foscarnet; Ganciclovir; Hepatitis B Virus, Duck; Immunoblotting; Liver; Viral Core Proteins; Virus Replication | 1996 |
Current and experimental therapeutic options for cytomegalovirus disease.
Topics: Administration, Oral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Delayed-Action Preparations; Foscarnet; Ganciclovir; Guanine; Humans; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds | 1996 |
Current management of cytomegalovirus infection: treatment and prophylaxis.
Topics: Administration, Oral; Anti-Bacterial Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Recurrence | 1996 |
Cytomegalovirus resistance to antiviral therapies.
Topics: Administration, Oral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Treatment Outcome | 1996 |
European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Data Collection; Drug Resistance, Microbial; Europe; Foscarnet; Ganciclovir; Herpesviridae; Herpesviridae Infections; Herpesvirus 3, Human; Humans; Simplexvirus; Surveys and Questionnaires; Vidarabine | 1996 |
Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antibodies, Viral; Cell Transplantation; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Feasibility Studies; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Pilot Projects; Transplantation, Homologous; Virus Activation | 1996 |
A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs.
Topics: Antigens, Viral; Antiviral Agents; Cidofovir; Cytosine; Drug Evaluation; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Organophosphonates; Organophosphorus Compounds; Reproducibility of Results | 1996 |
Some antivirals may lower Kaposi's sarcoma risk.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Sarcoma, Kaposi | 1996 |
Nephrogenic diabetes insipidus associated with foscarnet--a case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Diarrhea; Foscarnet; Ganciclovir; Humans; Male; Osmolar Concentration; Polyuria; Reverse Transcriptase Inhibitors; Urine | 1996 |
Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Drug Therapy, Combination; Eye Infections, Viral; Female; Follow-Up Studies; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Male; Middle Aged; Optic Disk; Optic Neuritis; Prognosis; Visual Acuity | 1996 |
In vitro evaluation of polymeric matrix and porous biodegradable reservoir devices for slow-release drug delivery.
Topics: Antiviral Agents; Biodegradation, Environmental; Delayed-Action Preparations; Drug Delivery Systems; Fluoresceins; Fluorouracil; Foscarnet; Ganciclovir; In Vitro Techniques; Microscopy, Electron, Scanning; Polyesters; Porosity | 1996 |
Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment.
Topics: Antiviral Agents; Bone Marrow Transplantation; CD58 Antigens; Cytomegalovirus; Cytomegalovirus Infections; Fibroblasts; Foscarnet; Ganciclovir; Graft Rejection; Humans; Intercellular Adhesion Molecule-1; Organ Transplantation; Up-Regulation; Viral Proteins | 1996 |
Combined ganciclovir and foscarnet in pediatric cytomegalovirus retinitis.
Topics: Child, Preschool; Cytomegalovirus Retinitis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Foscarnet; Ganciclovir; Humans | 1996 |
Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct).
Topics: Adolescent; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Transplantation, Homologous | 1996 |
Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
Topics: Adolescent; Adult; Antigens, Viral; Antiviral Agents; Chemoprevention; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Microbial; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukocytes; Male; Middle Aged; Risk Factors; Survival Rate; Viremia | 1996 |
[Early diagnosis and treatment of cytomegalovirus polyradiculoneuritis in a child infected by HIV].
Topics: AIDS-Related Opportunistic Infections; Child; Cytomegalovirus Infections; Drug Therapy, Combination; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Polyradiculoneuropathy | 1996 |
Successful treatment of progressive outer retinal necrosis syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Female; Foscarnet; Fundus Oculi; Ganciclovir; Herpes Zoster; Herpes Zoster Ophthalmicus; Humans; Infusions, Intravenous; Male; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Silicone Oils; Visual Acuity; Vitrectomy | 1996 |
Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation.
Topics: Adolescent; Cytomegalovirus; Cytomegalovirus Infections; DNA Mutational Analysis; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Liver Transplantation; Male | 1997 |
Repair of retinal detachments due to herpes varicella-zoster virus retinitis in patients with acquired immune deficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Male; Retinal Detachment; Retinitis; Silicone Oils; Visual Acuity; Vitrectomy | 1997 |
[Foscarnet therapy for ganciclovir-refractory cytomegalovirus hepatitis in a patient who underwent bone marrow transplantation from an unrelated donor].
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cytomegalovirus Infections; Drug Resistance; Female; Foscarnet; Ganciclovir; Hepatitis, Viral, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1997 |
Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Male; Recurrence; Retina | 1995 |
Quantitative systemic and local evaluation of the antiviral effect of ganciclovir and foscarnet induction treatment on human cytomegalovirus gastrointestinal disease of patients with AIDS. Italian Foscarnet GID Study Group.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Gastrointestinal Diseases; HIV-1; Humans; Viral Load | 1997 |
New therapies for cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Prognosis; Retinitis | 1997 |
Central venous line infections in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Catheterization, Central Venous; Catheters, Indwelling; Cytomegalovirus Retinitis; Equipment Contamination; Female; Foscarnet; Ganciclovir; Humans; Male; Sepsis; Survival Analysis; Wound Infection | 1997 |
The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged | 1996 |
Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Base Sequence; Cytomegalovirus; Cytomegalovirus Infections; DNA Primers; DNA-Directed DNA Polymerase; Foscarnet; Ganciclovir; Genotype; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction | 1997 |
Management of varicella zoster virus retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Antiviral Agents; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Middle Aged; Retinal Detachment; Retinitis; Retrospective Studies; Treatment Outcome; Visual Acuity | 1997 |
Cytomegalovirus retinitis: decreased risk of bilaterality with increased use of systemic treatment. Swiss HIV Cohort Study Group.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 1997 |
Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Foscarnet; Ganciclovir; Humans; Reverse Transcriptase Inhibitors; Salvage Therapy | 1997 |
Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA Probes; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Methylurea Compounds; Nucleic Acid Hybridization; Organophosphonates; Organophosphorus Compounds; Phorbol Esters; Pyridines; Sarcoma, Kaposi; Tumor Cells, Cultured; Valine; Virus Replication | 1997 |
Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods.
Topics: Antibodies, Viral; Antiviral Agents; Biopsy; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulin M; Liver; Liver Transplantation; Nucleic Acid Hybridization | 1997 |
Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays.
Topics: Antigens, Viral; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Cytopathogenic Effect, Viral; DNA, Viral; Fibroblasts; Foscarnet; Ganciclovir; Genetic Techniques; Humans; Immunoenzyme Techniques; Polyradiculopathy; Sensitivity and Specificity | 1997 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases | 1997 |
Concurrent ganciclovir and foscarnet treatment for cytomegalovirus encephalitis and retinitis in an infant with acquired immunodeficiency syndrome: case report and review.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Retinitis | 1997 |
Identification and treatment of cytomegalovirus retinitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans | 1997 |
Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Recombination, Genetic; RNA-Directed DNA Polymerase; Sequence Analysis, DNA | 1997 |
Antiviral susceptibility testing-flow cytometric analysis (AST-FCA) for the detection of cytomegalovirus drug resistance.
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Dose-Response Relationship, Drug; Flow Cytometry; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 1997 |
Quantitative cytomegalovirus (CMV) antigenaemia during antiviral treatment of AIDS-related CMV disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Antigens, Viral; Antiviral Agents; Biomarkers; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Phosphoproteins; Viral Matrix Proteins | 1997 |
In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
Topics: Acyclovir; Antiviral Agents; Carcinogens; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phorbol 12,13-Dibutyrate; Sarcoma, Kaposi; Thymidine; Tumor Cells, Cultured; Virus Latency | 1997 |
Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis.
Topics: Anemia, Aplastic; Antiviral Agents; Biopsy; Bone Marrow; Bone Marrow Transplantation; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Hepatitis, Viral, Human; Humans; Liver Failure, Acute; Liver Transplantation; Male; Polymerase Chain Reaction | 1997 |
Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient.
Topics: Adult; Antiviral Agents; Aqueous Humor; Bone Marrow Transplantation; Cytomegalovirus Retinitis; Female; Foscarnet; Ganciclovir; Humans; Injections, Intralesional; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1997 |
Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet.
Topics: Acyclovir; Antiviral Agents; Fibroblasts; Flow Cytometry; Foscarnet; Ganciclovir; Herpes Simplex; Herpesvirus 1, Human; Humans; Kinetics; Microbial Sensitivity Tests; Phosphorylation; Viral Envelope Proteins | 1997 |
Intravitreal ganciclovir treatment in progressive outer retinal necrosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Infusions, Intravenous; Laser Coagulation; Male; Retinal Necrosis Syndrome, Acute; Vitreous Body | 1997 |
Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Male; Middle Aged; Treatment Outcome; Vitreous Body | 1996 |
Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds | 1998 |
New issues in the management of cytomegalovirus retinitis in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1998 |
Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: Acetazolamide; Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Carbonic Anhydrase Inhibitors; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Fluorescein Angiography; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Ketorolac Tromethamine; Macular Edema; Male; Retrospective Studies; Tolmetin; Tromethamine; Visual Acuity | 1998 |
How to treat the cytomegalovirus troll.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Recurrence; Treatment Outcome | 1998 |
Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV; HIV Protease Inhibitors; Humans; Male; Polymerase Chain Reaction; Recurrence; RNA, Viral; Viral Load | 1998 |
The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Male; Middle Aged; Recurrence; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Treatment Outcome; Visual Acuity | 1998 |
Lack of efficacy of cidofovir in treating AIDS-related cytomegalovirus retinitis after long-term treatment with ganciclovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Recurrence | 1998 |
[Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir].
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Glucocorticoids; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure; Methylprednisolone; Virus Activation | 1997 |
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Lung Diseases; Nervous System Diseases; Organophosphonates; Organophosphorus Compounds; Retinitis | 1998 |
Prophylactic argon laser coagulation for rhegmatogenous retinal detachment in AIDS patients with cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Laser Coagulation; Retina; Retinal Detachment; Retinal Perforations | 1998 |
Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Recombination, Genetic; Virus Replication | 1998 |
Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Antiviral Agents; Bone Marrow Transplantation; Female; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Leukemia, Myeloid; Postoperative Complications; Transplantation, Homologous | 1998 |
Immunohistochemical localization of ganciclovir in the human retina.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Delayed-Action Preparations; Fluorescent Antibody Technique, Indirect; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Male; Middle Aged; Retina; Vitreous Body | 1998 |
Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Body Fluids; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Retrospective Studies; Treatment Outcome | 1998 |
Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Alanine; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Male; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Reverse Transcriptase Inhibitors; Valine; Viral Proteins | 1998 |
Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
Topics: AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antigens, Viral; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Fibroblasts; Fluorescent Antibody Technique, Direct; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; In Situ Hybridization; Leukocytes; Polymerase Chain Reaction; Viral Load | 1998 |
Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Baltimore; Blood; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Prognosis; Prospective Studies; Survival Rate; Urine; Viremia | 1998 |
A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains.
Topics: Antiviral Agents; Coculture Techniques; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Viral Plaque Assay | 1998 |
In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genotype; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Recurrence | 1998 |
Risk of developing CMV retinitis following non-ocular CMV end organ disease in AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Biopsy; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Middle Aged; Risk Factors | 1998 |
Human herpesvirus 8 DNA load in leukocytes of human immunodeficiency virus-infected subjects: correlation with the presence of Kaposi's sarcoma and response to anticytomegalovirus therapy.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpesvirus 8, Human; HIV Infections; Humans; Leukocytes; Sarcoma, Kaposi; Viral Load | 1999 |
Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Middle Aged; Retrospective Studies; Sarcoma, Kaposi; Time Factors | 1999 |
[Cytomegalovirus (CMV) retinitis in AIDS. Gancilovir implantation in comparison with systemic therapy].
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cytomegalovirus Retinitis; Drug Implants; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Quality of Life; Retrospective Studies | 1999 |
Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Foscarnet; Ganciclovir; Gene Expression; Humans; Leukocytes, Mononuclear; Phosphoproteins; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Viral; Sensitivity and Specificity; Viral Load; Viral Matrix Proteins; Viremia | 1999 |
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients.
Topics: Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pneumonia, Viral; Transplantation, Homologous; Treatment Outcome | 1999 |
Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories.
Topics: Antiviral Agents; Codon; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genotype; Humans; Sequence Homology, Amino Acid | 1999 |
Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; HIV Infections; Humans; Incidence; Indinavir; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Retrospective Studies; Sarcoma, Kaposi | 1999 |
Ganciclovir resistance in a heart transplant recipient infected by cytomegalovirus.
Topics: Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Heart Transplantation; Humans; Male; Microbial Sensitivity Tests | 1999 |
HHV-6-related secondary graft failure following allogeneic bone marrow transplantation.
Topics: Antiviral Agents; Bone Marrow Diseases; Bone Marrow Transplantation; Child; Diagnosis, Differential; Fatal Outcome; Foscarnet; Ganciclovir; Graft Rejection; Herpesviridae Infections; Herpesvirus 6, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 1999 |
Fatal herpesvirus-6 encephalitis in a recipient of a T-cell-depleted peripheral blood stem cell transplant from a 3-loci mismatched related donor.
Topics: Cytomegalovirus Infections; DNA, Viral; Encephalitis, Viral; Fatal Outcome; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesviridae Infections; Herpesvirus 6, Human; Histocompatibility; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Male; Middle Aged; Polymerase Chain Reaction; Tissue Donors; Transplantation Conditioning; Virus Activation | 2000 |
The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts.
Topics: Antiviral Agents; Cells, Cultured; Chemotaxis, Leukocyte; Cidofovir; Cytomegalovirus Infections; Cytosine; Fibroblasts; Foscarnet; Ganciclovir; Humans; Immunohistochemistry; Intercellular Adhesion Molecule-1; Interleukin-8; Neutrophils; Oligonucleotides, Antisense; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; Thionucleotides; Up-Regulation | 2000 |
A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Fibroblasts; Foscarnet; Ganciclovir; Humans; Laboratories; Microbial Sensitivity Tests; Reproducibility of Results; Viral Plaque Assay | 2000 |
Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Maryland; Retrospective Studies; Risk Factors; Sex Factors; Zidovudine | 1999 |
Antiviral activity of ganciclovir elaidic acid ester against herpesviruses.
Topics: Acyclovir; Administration, Oral; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Cytomegalovirus; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesvirus 3, Human; HIV-1; HIV-2; Humans; Mice; Simplexvirus | 2000 |
[Severe cytomegalovirus enteritis in AIDS. Favorable outcome of medical treatment].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Celiac Disease; Cytomegalovirus Infections; Foscarnet; Ganciclovir; HIV Protease Inhibitors; Humans; Lamivudine; Male; Nelfinavir; Parenteral Nutrition; Pentamidine; Protein-Losing Enteropathies; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Treatment Outcome | 2000 |
Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
Topics: Antibodies, Monoclonal; Antigens, Surface; Antigens, Viral; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Flow Cytometry; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Organophosphonates; Organophosphorus Compounds; Reproducibility of Results | 2000 |
Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: case-control and historical cohort studies.
Topics: Acyclovir; Adult; Antiviral Agents; Case-Control Studies; Cohort Studies; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Foscarnet; Ganciclovir; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Time Factors | 2000 |
Outcome of AIDS-associated cytomegalovirus colitis in the era of potent antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cohort Studies; Colitis; Cytomegalovirus Infections; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Protease Inhibitors; Humans; Male; Proportional Hazards Models; Recurrence; Survival Rate; Time Factors; Treatment Outcome | 2000 |
Cidofovir: new preparation. Of help in CMV retinitis.
Topics: Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclovir; Humans; Treatment Outcome | 1998 |
Ganciclovir resistance: a matter of time and titre.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Disease Management; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Immunocompromised Host; Organ Transplantation; Simplexvirus | 2000 |
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.
Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Immunosuppression Therapy; Inhibitory Concentration 50; Kidney Transplantation; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Opportunistic Infections; Organ Transplantation; Pancreas Transplantation; Phosphotransferases (Alcohol Group Acceptor); Retrospective Studies | 2000 |
Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Infections; Homosexuality, Male; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Retrospective Studies; Risk Factors; Sarcoma, Kaposi; Skin Neoplasms | 2000 |
[Stopping secondary prevention in AIDS patients with inactive CMV retinitis treated with HAART (highly active antiretroviral therapy)].
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 2000 |
Growth phenotypes of cytomegalovirus isolates do not correlate with glycoprotein B, major immediate early genotypes or antiviral sensitivity.
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Cytopathogenic Effect, Viral; Fibroblasts; Foscarnet; Ganciclovir; Humans; Immediate-Early Proteins; Phenotype; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Viral Envelope Proteins; Viral Proteins; Virus Replication | 2000 |
Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes.
Topics: Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Follow-Up Studies; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Mutation; Phosphotransferases (Alcohol Group Acceptor); Time Factors; Treatment Outcome; Viral Proteins | 2000 |
A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Ganciclovir; Gene Deletion; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases; Transfection | 2000 |
Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient.
Topics: Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Fatal Outcome; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pneumonia, Viral; Polymerase Chain Reaction; Postoperative Complications | 2000 |
Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antigens, Viral; Antiviral Agents; Cause of Death; Child; Child, Preschool; Cytomegalovirus Infections; DNA, Viral; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Phosphoproteins; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Viral Load; Viral Matrix Proteins; Viremia; Virus Activation | 2001 |
Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma.
Topics: Adult; Aged; Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Fever; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Postoperative Complications; Retrospective Studies; Transplantation, Autologous; Virus Activation | 2001 |
Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Topics: Adult; Antiviral Agents; Chronic Disease; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Treatment Outcome; Virus Activation | 2001 |
Failure of cidofovir to reduce CMV-antigenemia in a child transplanted from a matched unrelated donor.
Topics: Adenoviridae; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Evaluation; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Male; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 2001 |
Frosted branch angiitis in a child with HIV infection.
Topics: Antiviral Agents; Child; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Glucocorticoids; HIV Infections; Humans; Male; Retinal Diseases; Retinal Vessels; Vasculitis | 2001 |
High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Treatment Outcome; Visual Acuity; Vitreous Body | 2001 |
Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits.
Topics: Animals; Antiviral Agents; Biological Availability; Chromatography, High Pressure Liquid; Foscarnet; Ganciclovir; Injections; Rabbits; Retina; Vitreous Body | 2001 |
Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality.
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lymphocyte Count; Male; Middle Aged; Polymerase Chain Reaction; Risk; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Virus Activation | 2001 |
Flow cytometric evaluation of antiviral agents against human herpesvirus 6.
Topics: Acyclovir; Animals; Antigens, Viral; Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Viral Proteins | 2001 |
CMV retinitis: a clinical management update.
Topics: AIDS-Related Opportunistic Infections; Algorithms; Antiviral Agents; Cidofovir; Clinical Protocols; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Injections; Organophosphonates; Organophosphorus Compounds; Patient Participation; Vitreous Body | 1996 |
Support for new foscarnet indication for AIDS-related CMV retinitis is mixed.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Combinations; Foscarnet; Ganciclovir; Humans | 1997 |
Advances in the treatment of CMV.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Drug Therapy, Combination; Eye; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Quality of Life | 1995 |
New developments in the delivery of ganciclovir for cytomegalovirus (CMV retinitis).
Topics: Administration, Oral; Cytomegalovirus Retinitis; Drug Costs; Drug Implants; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous | 1995 |
New drug applications sought.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Cytomegalovirus Retinitis; Drug Approval; Drug Implants; Drug Labeling; Foscarnet; Ganciclovir; Herpes Simplex; HIV Infections; Infusions, Intravenous; Mycobacterium avium-intracellulare Infection; Stavudine; United States; United States Food and Drug Administration | 1995 |
Medicare may not reimburse for certain AIDS and cancer drugs.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Insurance, Pharmaceutical Services; Medicare; Neoplasms; Vancomycin | 1995 |
Advances in treatment for cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antiviral Agents; Cytomegalovirus Retinitis; Drug Implants; Drug Interactions; Foscarnet; Ganciclovir; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Kidney; Neutropenia | 1995 |
Combination therapy improves CMV treatment.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Quality of Life | 1996 |
Detecting CMV retinitis: know what to look for. Treatment is effective but not pleasant.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antiviral Agents; Cytomegalovirus Retinitis; Drug Implants; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans | 1996 |
CMV: the other virus.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Implants; Foscarnet; Ganciclovir; Humans | 1996 |
Guide to CMV management.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Drug Implants; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Quality of Life; Thionucleotides | 1996 |
Intraocular therapy for cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Implants; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Visual Acuity | 1996 |
CMV resistance: "more complicated than we thought".
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans | 1996 |
Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Central Nervous System Diseases; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Digestive System Diseases; Foscarnet; Ganciclovir; Humans; Valacyclovir; Valine | 1996 |
Two-drug treatment effective against recurrent CMV retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Recurrence | 1996 |
Responding to CMV neurologic infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Central Nervous System Diseases; Cytomegalovirus Infections; Diagnosis, Differential; Foscarnet; Ganciclovir; Humans; Polymerase Chain Reaction | 1996 |
Foscavir receives new indication.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpes Simplex; Humans; United States; United States Food and Drug Administration | 1997 |
Fomivirsen.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Disease Progression; Foscarnet; Ganciclovir; Health Services Accessibility; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides | 1998 |
Progressive outer retinal necrosis syndrome in a lymphoma patient with good visual outcome.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Immunoglobulins, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Retinal Necrosis Syndrome, Acute; Treatment Outcome; Visual Acuity | 2001 |
Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
Topics: Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA Primers; DNA Probes; Drug Therapy, Combination; Foscarnet; Ganciclovir; Gene Expression Regulation, Viral; Glycoproteins; Graft Rejection; Humans; Immediate-Early Proteins; Immunosuppressive Agents; Kinetics; Lung Transplantation; Membrane Proteins; Phosphoproteins; Postoperative Complications; RNA-Binding Proteins; RNA, Messenger; Time Factors; Trans-Activators; Transcription, Genetic; Viral Matrix Proteins; Viral Proteins | 2001 |
Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches.
Topics: Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Phosphoproteins; Recurrence; Salvage Therapy; Time Factors; Transplantation, Homologous; Viral Matrix Proteins; Viremia | 2001 |
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA.
Topics: Adolescent; Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Infant; Nucleic Acid Amplification Techniques; RNA, Viral | 2001 |
Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance.
Topics: Antiviral Agents; Bone Marrow Transplantation; Cerebral Ventricles; Child; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Combinations; Drug Resistance, Viral; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds | 2001 |
Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
Topics: Antiviral Agents; Codon; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Foscarnet; Ganciclovir; Genes, Viral; Genetic Variation; Humans; Microbial Sensitivity Tests; Phosphotransferases; Virus Replication | 2001 |
[In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Drug Resistance, Viral; Fibroblasts; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Reference Values; Viral Plaque Assay; Virus Replication | 2001 |
T-cell activation response to allogeneic CMV-infected endothelial cells is not prevented by ganciclovir or foscarnet: implications for transplant vascular sclerosis.
Topics: Antiviral Agents; Blood Vessels; Cytomegalovirus; Endothelium, Vascular; Foscarnet; Ganciclovir; Graft Rejection; Humans; Lymphocyte Activation; Sclerosis; T-Lymphocytes | 2002 |
Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment.
Topics: Adult; Aged; Amino Acid Sequence; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mutation; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins | 2001 |
[Cytomegalovirus sensitivity to anti-retroviral agents in patients infected with the human immunodeficiency virus with chorioretinitis in Spain].
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Chorioretinitis; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Spain | 2001 |
Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Encephalitis, Viral; Etoposide; Fatal Outcome; Female; Fetal Blood; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Immunocompromised Host; Korsakoff Syndrome; Leukemia, Myeloid, Acute; Recurrence; Roseolovirus Infections; Transplantation Conditioning; Transplantation, Homologous; Virus Activation | 2001 |
Clinicopathologic reports, case reports, and small case series: cytomegalovirus retinitis in patients with Good syndrome.
Topics: Agammaglobulinemia; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Female; Foscarnet; Ganciclovir; Humans; Middle Aged; Retinal Detachment; Syndrome; Thymoma; Thymus Neoplasms; Vitreous Body | 2002 |
Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
Topics: Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Transplants; Treatment Outcome | 2002 |
Necrotizing herpetic retinopathy associated with Ramsay Hunt syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hearing Loss, Bilateral; Hearing Tests; Herpes Zoster Ophthalmicus; Herpes Zoster Oticus; Humans; Retinal Necrosis Syndrome, Acute; Syndrome; Visual Acuity | 2002 |
Antiviral therapy for cytomegalovirus infections in pediatric patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Infant; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Time Factors | 2002 |
The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Infant; Lymphocyte Depletion; Male; Middle Aged; Platelet Transfusion; Postoperative Complications; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous | 2002 |
Intravitreal antivirals in the management of patients with acquired immunodeficiency syndrome with progressive outer retinal necrosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections; Male; Retinal Necrosis Syndrome, Acute; Vitreous Body | 2002 |
Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants.
Topics: Adenine; Antiviral Agents; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Ganciclovir; Guanine; Humans; Immunocompromised Host; Phosphotransferases (Alcohol Group Acceptor) | 2002 |
Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections, Intravenous; Male; Organophosphonates; Organophosphorus Compounds; Retinitis; Vitreous Body | 2002 |
Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection.
Topics: Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Organ Transplantation | 2002 |
Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient.
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Encephalitis, Viral; Foscarnet; Ganciclovir; Humans; Leukodystrophy, Metachromatic; Male | 2002 |
Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase.
Topics: Amino Acid Substitution; Cells, Cultured; Codon; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Fibroblasts; Foscarnet; Ganciclovir; Genes, Viral; Humans; Lung; Mutation, Missense; Phenotype; Point Mutation; Sequence Analysis, Protein; Viral Proteins; Viral Structural Proteins | 2003 |
Progressive outer retinal necrosis in immunocompetent patients treated initially for optic neuropathy with systemic corticosteroids.
Topics: Acyclovir; Aged; Antiviral Agents; Aqueous Humor; Blindness; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Glucocorticoids; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Immunocompromised Host; Middle Aged; Multiple Sclerosis; Optic Neuritis; Polymerase Chain Reaction; Prednisone; Pupil Disorders; Retinal Necrosis Syndrome, Acute; Retrospective Studies | 2003 |
Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Cells, Cultured; Cidofovir; Cytosine; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 4, Human; Herpesvirus 6, Human; Herpesvirus 8, Human; Humans; Organophosphonates; Organophosphorus Compounds | 2003 |
Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
Topics: Acyclovir; Animals; Antiviral Agents; Cattle; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Drug Synergism; Foscarnet; Ganciclovir; Inhibitory Concentration 50; Lactoferrin; Organophosphonates; Organophosphorus Compounds | 2003 |
Cytomegalovirus infection resistant to ganciclovir in a renal transplant patient.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Cadaver; Candidiasis; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Male; Postoperative Complications; Streptococcal Infections; Streptococcus pneumoniae; Tissue Donors; Treatment Outcome | 2003 |
Successful treatment with combination of systemic antiviral drugs and intravitreal ganciclovir injections in the management of severe necrotizing herpetic retinitis.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections; Male; Necrosis; Retinitis; Severity of Illness Index; Visual Acuity; Vitreous Body | 2003 |
Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423.
Topics: Antiviral Agents; Carrier Proteins; Cell Cycle; DNA-Directed DNA Polymerase; Foscarnet; Ganciclovir; Gene Expression; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Indolizines; Intracellular Signaling Peptides and Proteins; Microbial Sensitivity Tests; Phosphotransferases (Alcohol Group Acceptor); Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines; Transcription, Genetic; Tumor Cells, Cultured; Virus Replication | 2004 |
Recurrent cytomegalovirus disease, visceral leishmaniosis, and Legionella pneumonia after liver transplantation: a case report.
Topics: Anti-Bacterial Agents; Antimony Sodium Gluconate; Antiviral Agents; Bone and Bones; Clarithromycin; Cross Infection; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Legionnaires' Disease; Leishmaniasis, Visceral; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Schistosomicides; Viral Load | 2004 |
Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy.
Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; Female; Foscarnet; Ganciclovir; Humans; Lymphoma, T-Cell; Molecular Epidemiology; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA | 2004 |
In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
Topics: Acyclovir; Animals; Antiviral Agents; Cats; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Foscarnet; Ganciclovir; Guanine; Idoxuridine; In Vitro Techniques; Inhibitory Concentration 50; Organophosphonates; Organophosphorus Compounds; Varicellovirus; Virus Replication | 2004 |
Susceptibility of porcine cytomegalovirus to antiviral drugs.
Topics: Animals; Antiviral Agents; Cell Survival; Cidofovir; Cytomegalovirus; Cytosine; DNA, Viral; Fluorescent Antibody Technique, Indirect; Foscarnet; Ganciclovir; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; Swine; Virus Replication | 2004 |
How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients.
Topics: Adolescent; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Evolution, Molecular; Fatal Outcome; Female; Foscarnet; Ganciclovir; Gene Products, pol; Hematopoietic Stem Cell Transplantation; Humans; Male; Mutation; Treatment Outcome | 2005 |
The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production.
Topics: Antiviral Agents; Apoptosis; Cell Line; DNA-Directed DNA Polymerase; Foscarnet; Ganciclovir; Herpesvirus 8, Human; Humans; Lymphoma; Nucleic Acid Synthesis Inhibitors; RNA, Messenger; Valproic Acid; Viral Proteins; Virus Assembly; Virus Replication | 2005 |
Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation.
Topics: Adolescent; Antigens, Viral; Antiviral Agents; Child; Cidofovir; Creatinine; Cytomegalovirus Infections; Cytosine; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Organophosphonates; Premedication; Virus Activation | 2005 |
Early onset of ganciclovir-resistant cytomegalovirus infection in a lung-transplant recipient.
Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Lung Transplantation; Postoperative Complications | 2005 |
An in vitro study of the design and development of a novel doughnut-shaped minitablet for intraocular implantation.
Topics: Anti-Retroviral Agents; Aqueous Humor; Drug Carriers; Drug Implants; Eye; Foscarnet; Ganciclovir; Hardness; Humans; In Vitro Techniques; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Tablets; Viscosity | 2006 |
Cytomegalovirus colitis in children with inflammatory bowel disease.
Topics: Antiviral Agents; Child; Colitis; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Inflammatory Bowel Diseases; Treatment Outcome | 2006 |
Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Chronic Disease; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Eye Infections, Viral; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Glaucoma, Open-Angle; Gonioscopy; Humans; Iridocyclitis; Male; Middle Aged; Recurrence; Retrospective Studies; Uveitis, Anterior; Valganciclovir; Vitreous Body | 2006 |
Fatal haemolytic uraemic syndrome in an AIDS patient with disseminated adenovirus and cytomegalovirus co-infection.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenovirus Infections, Human; Colitis; Cytomegalovirus Infections; Enteritis; Fatal Outcome; Female; Foscarnet; Ganciclovir; Hemolytic-Uremic Syndrome; Humans; Respiratory Distress Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.
Topics: Antiviral Agents; Benzimidazoles; Cidofovir; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Ribonucleosides; Viral Proteins | 2006 |
Pancreatic hyperamylasemia and hyperlipasemia in association with cytomegalovirus infection following unrelated cord blood transplantation for acute myelogenous leukemia.
Topics: Adult; Amylases; Antiviral Agents; Cord Blood Stem Cell Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Hyperamylasemia; Leukemia, Myeloid, Acute; Male; Pancreatitis; Transplantation, Homologous | 2006 |
Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant.
Topics: Aged; Antiviral Agents; Behcet Syndrome; Cytomegalovirus Retinitis; Drug Implants; Fluocinolone Acetonide; Foscarnet; Ganciclovir; Glucocorticoids; Humans; Immunocompromised Host; Macular Edema; Male; Retrospective Studies; Uveitis | 2007 |
In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Cell Survival; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Epithelial Cells; Foscarnet; Ganciclovir; Herpesvirus 1, Equid; Horses; Lung; Organophosphonates | 2007 |
Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation.
Topics: Adolescent; Adult; Aged; Antigens, Viral; Antiviral Agents; Cord Blood Stem Cell Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Enterocolitis; Exanthema; Female; Foscarnet; Ganciclovir; Humans; Japan; Male; Middle Aged; Neoplasms; Postoperative Complications; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Water-Electrolyte Imbalance | 2007 |
Persistent erythema multiforme and CMV infection.
Topics: Antiviral Agents; Bone Marrow Diseases; Cytomegalovirus Infections; Erythema Multiforme; Fatal Outcome; Female; Foscarnet; Ganciclovir; Hepatitis C; Humans; Liver Transplantation; Middle Aged; Pancytopenia; Skin | 2007 |
Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients.
Topics: Adolescent; Adult; Aged; Cord Blood Stem Cell Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Transplantation Conditioning | 2007 |
Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Retinitis; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Male; Middle Aged; Organ Transplantation; Prognosis; Severity of Illness Index | 2008 |
Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.
Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Disease Progression; DNA, Viral; Female; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Immunohistochemistry; Male; Middle Aged; Phosphoproteins; Polymerase Chain Reaction; Transplantation; Viral Matrix Proteins | 2007 |
Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
Topics: Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Multiple, Viral; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Retrospective Studies; X-Linked Combined Immunodeficiency Diseases | 2007 |
Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
Topics: Antibodies, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Fatal Outcome; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Liver Failure; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction | 2007 |
Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.
Topics: Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; Benzimidazoles; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Models, Molecular; Molecular Sequence Data; Mutant Proteins; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Protein Structure, Tertiary; Ribonucleosides; Sequence Alignment; Viral Proteins | 2008 |
A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Topics: Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Genetic Predisposition to Disease; Humans; Lung Transplantation; Male; Middle Aged; Mutation; Opportunistic Infections; Phosphotransferases (Alcohol Group Acceptor); Postoperative Complications; Retrospective Studies; Treatment Outcome | 2007 |
Studies on a novel doughnut-shaped minitablet for intraocular drug delivery.
Topics: Administration, Topical; Antiviral Agents; Aqueous Humor; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Implants; Foscarnet; Ganciclovir; Hydrogen-Ion Concentration; Kinetics; Models, Chemical; Models, Statistical; Polyglactin 910; Research Design; Solubility; Tablets; Technology, Pharmaceutical; Viscosity | 2007 |
Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.
Topics: Antiviral Agents; Brain; Confusion; Diagnosis, Differential; DNA, Viral; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Herpesvirus 6, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Limbic Encephalitis; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Predictive Value of Tests; Roseolovirus Infections; Stem Cell Transplantation; Treatment Outcome | 2008 |
Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locus.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phenotype; Protein Structure, Tertiary; Viral Proteins | 2008 |
Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Cohort Studies; Cornea; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Herpesvirus 1, Human; Humans; Keratitis, Herpetic; Male; Middle Aged; Prevalence; Thymidine Kinase | 2008 |
Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
Topics: Alemtuzumab; Anemia, Refractory, with Excess of Blasts; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antiviral Agents; Base Sequence; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Viral Proteins; Virus Activation | 2008 |
Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir.
Topics: Adult; Antiviral Agents; Cerebrospinal Fluid; Encephalomyelitis; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Male; Proviruses; Roseolovirus Infections; Serum; Treatment Outcome | 2008 |
Successful treatment of cytomegalovirus polyradiculopathy in a 9-year-old child with congenital human immunodeficiency virus infection.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Brain; Child; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Infections; Humans; Magnetic Resonance Imaging; Polyradiculopathy; Spine; Treatment Outcome | 2009 |
Cytomegalovirus retinitis.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antibodies, Viral; Aqueous Humor; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Therapy, Combination; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell; Male; Middle Aged; Opportunistic Infections; Polymerase Chain Reaction; Transplantation Conditioning; Transplantation, Homologous; Visual Acuity; Vitreous Body | 2009 |
[Disease by CMV resistant to Ganciclovir. Should plasma valganciclovir levels be monitored in high risk patients?].
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Gastric Mucosa; Humans; Immunoglobulins, Intravenous; Kidney Transplantation; Mutation, Missense; Phosphotransferases (Alcohol Group Acceptor); Postoperative Complications; Risk; Valganciclovir; Viral Load | 2009 |
Donor CMV serostatus not predictive of relapse in D-/R- pediatric HCT.
Topics: Acyclovir; Adolescent; Adult; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Ethnicity; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Living Donors; Male; Middle Aged; Myeloablative Agonists; Postoperative Complications; Premedication; Proportional Hazards Models; Recurrence; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Virus Activation; Young Adult | 2009 |
Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Male; Proportional Hazards Models; Prospective Studies; Survival Rate; Time Factors; Viral Load | 2010 |
Sustained release of ganciclovir and foscarnet from biodegradable scleral plugs for the treatment of cytomegalovirus retinitis.
Topics: Animals; Biocompatible Materials; Chromatography, High Pressure Liquid; Conjunctiva; Cytomegalovirus Retinitis; Dark Adaptation; Delayed-Action Preparations; Electroretinography; Foscarnet; Ganciclovir; Prosthesis Implantation; Rabbits; Sclera; Sclerostomy | 2010 |
Fundus autofluorescence changes in cytomegalovirus retinitis.
Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Cytomegalovirus Retinitis; Drug Implants; Female; Fluorescein Angiography; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Retinal Pigment Epithelium; Retrospective Studies; Valganciclovir | 2010 |
Long-term follow-up of acute retinal necrosis.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Eye Infections, Viral; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Herpesvirus 3, Human; Humans; Injections; Male; Middle Aged; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Simplexvirus; Visual Acuity; Vitreous Body | 2010 |
[Cytomegalovirus infection--diagnostic and therapeutic difficulties in neonatal intensive care unit].
Topics: Antiviral Agents; Cross-Sectional Studies; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunoglobulin G; Immunoglobulin M; Incidence; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Poland; Retrospective Studies; Sensitivity and Specificity; Serologic Tests; Urine | 2010 |
Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity.
Topics: Animals; Antiviral Agents; Cells, Cultured; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Fibroblasts; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Mutation; Rabbits; Recombination, Genetic; Reticulocytes; Virus Replication | 2010 |
Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor.
Topics: Adolescent; Adult; Aged; Cytomegalovirus Infections; Drug Evaluation; Family; Female; Foscarnet; Ganciclovir; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |
Analysis of human cytomegalovirus glycoprotein N genotypes in Chinese hematopoietic stem cell transplant recipients.
Topics: Antiviral Agents; China; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Foscarnet; Ganciclovir; Genetic Variation; Genotype; Hematopoietic Stem Cell Transplantation; Humans; Male; Polymerase Chain Reaction; Viral Envelope Proteins; Viral Load | 2011 |
De novo thrombotic microangiopathy induced by cytomegalovirus infection leading to renal allograft loss.
Topics: Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Thrombotic Microangiopathies; Time Factors | 2010 |
Ganciclovir-resistant human herpesvirus-6 encephalitis in a liver transplant patient: a case report.
Topics: Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Liver Transplantation; Male; Polymerase Chain Reaction | 2011 |
Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy.
Topics: Antiviral Agents; Chromosomes, Artificial, Bacterial; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genomic Structural Variation; Humans; Mutation; Phenotype; Viral Proteins | 2011 |
Progressive outer retinal necrosis in a patient with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Injections, Intravenous; Intravitreal Injections; Middle Aged; Retina; Retinal Necrosis Syndrome, Acute; Visual Acuity | 2011 |
Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Incidence; Infant; Kidney; Kidney Transplantation; Male; Middle Aged; Mutation; Norway; Phosphotransferases (Alcohol Group Acceptor); Retrospective Studies; Transplantation; Treatment Outcome; Young Adult | 2011 |
Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet.
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; DNA-Directed DNA Polymerase; Foscarnet; Ganciclovir; Genotype; Humans; Mutation; Phenotype; Recombination, Genetic; Viral Proteins | 2011 |
Longitudinal analysis of human herpesvirus-8 DNA and antibodies in an Italian allogeneic stem cell transplant recipient.
Topics: Antibodies, Viral; Cidofovir; Cytosine; DNA, Viral; Encephalitis; Fatal Outcome; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Italy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Organophosphonates; Stem Cell Transplantation; Transplantation, Homologous | 2011 |
Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.
Topics: Alkaline Phosphatase; Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exonucleases; Foscarnet; Ganciclovir; Genes, Reporter; Genotype; Guanine; Humans; Inhibitory Concentration 50; Mutation; Organophosphonates; Phenotype; Viral Proteins; Virus Replication | 2012 |
Polymerase chain reaction-based ganciclovir resistance testing of ocular fluids for cytomegalovirus retinitis.
Topics: Adult; Aged; Antiviral Agents; Aqueous Humor; Cytomegalovirus; Cytomegalovirus Retinitis; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Genome, Viral; Genotype; Humans; Infant; Male; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Polymerase Chain Reaction; Retrospective Studies; Valganciclovir; Viral Proteins; Vitreous Body | 2012 |
Polymorphic ventricular tachycardia in a patient with herpes encephalitis.
Topics: Acute Disease; Acyclovir; Antiviral Agents; Defibrillators, Implantable; Electrocardiography; Encephalitis, Herpes Simplex; Female; Foscarnet; Ganciclovir; Headache; Heart Arrest; Herpesvirus 2, Human; Humans; Long QT Syndrome; Magnetic Resonance Imaging; Meningitis, Viral; Middle Aged; Seizures; Tachycardia, Ventricular; Torsades de Pointes | 2012 |
Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA, Viral; Drug Resistance, Viral; Eye; Female; Foscarnet; Ganciclovir; Humans; Organophosphonates; Plasma; Sequence Analysis, DNA | 2012 |
Case report: Multidrug-resistant cytomegalovirus in a modified multivisceral transplant recipient.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Kidney Transplantation; Leflunomide; Organophosphonates; Pancreas Transplantation; Recurrence; Stomach; Treatment Outcome | 2012 |
[Clinical analysis of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Child; Child, Preschool; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Transplantation, Homologous; Young Adult | 2012 |
[Q & A. Enteritis found in a young man].
Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Enteritis; Foscarnet; Ganciclovir; Humans; Male | 2011 |
Fever and pancytopenia in a patient with Crohn's disease.
Topics: Angiography; Antiviral Agents; Azathioprine; Cecum; Crohn Disease; Digestive System Surgical Procedures; Disease Progression; Female; Fever; Foscarnet; Ganciclovir; Gastrointestinal Hemorrhage; Humans; Ileitis; Ileum; Immunosuppression Therapy; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Male; Pancytopenia; Rectum; Treatment Outcome; Valganciclovir; Young Adult | 2013 |
The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection.
Topics: Adult; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Inhibitory Concentration 50; Male; Middle Aged; Mutation; Odds Ratio; Organ Transplantation; Phosphotransferases (Alcohol Group Acceptor); Prevalence; Recurrence; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2013 |
A possible coincidence of cytomegalovirus retinitis and intraocular lymphoma in a patient with systemic non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Eye Neoplasms; Female; Foscarnet; Ganciclovir; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Polymerase Chain Reaction; Rituximab; Valganciclovir; Vitrectomy | 2013 |
Cytomegalovirus retinitis in the absence of AIDS.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Seronegativity; Humans; Immunocompetence; Intravitreal Injections; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Valganciclovir | 2013 |
Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Aqueous Humor; CD4 Lymphocyte Count; Chronic Disease; Cytomegalovirus; Cytomegalovirus Retinitis; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Seronegativity; Humans; Male; Middle Aged; Necrosis; Polymerase Chain Reaction; Retinal Neovascularization; Retinal Vasculitis; Retinal Vessels; Retrospective Studies; Uveitis, Posterior; Valganciclovir; Vitreous Body | 2013 |
Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.
Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Cells, Cultured; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phenotype; Sequence Analysis, DNA | 2013 |
Cytomegalovirus polyradiculopathy of late onset in a young renal transplant recipient.
Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Polyradiculopathy; Time Factors; Valganciclovir | 2013 |
Persistent human herpesvirus-6 infection in patients with an inherited form of the virus.
Topics: Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Infectious Disease Transmission, Vertical; Prevalence; RNA, Viral; Roseolovirus Infections; Sequence Analysis, DNA; Treatment Outcome; United States; Valganciclovir; Virus Replication | 2013 |
Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides.
Topics: Adolescent; Adult; Antigens, Viral; Antiviral Agents; Blood Donors; Combined Modality Therapy; Cytomegalovirus; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Host-Pathogen Interactions; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Reproducibility of Results; Retrospective Studies; Transplantation, Homologous; Young Adult | 2013 |
Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
Topics: Antiviral Agents; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Foscarnet; Ganciclovir; Genes, Viral; Humans; Mutagenesis; Mutation, Missense; Organophosphonates; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Viral Proteins | 2013 |
Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens.
Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Viremia; Young Adult | 2014 |
In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action.
Topics: Antiviral Agents; Artemisinins; Butadienes; Cell Line; Cytomegalovirus; Digitoxin; Digoxin; Drug Combinations; Drug Interactions; Fibroblasts; Foscarnet; Ganciclovir; Humans; Indoles; Nitriles; Ouabain; Pyrroles; Sunitinib; Virus Replication | 2014 |
Cytomegalovirus mutants resistant to ganciclovir and cidofovir differ in susceptibilities to synguanol and its 6-ether and 6-thioether derivatives.
Topics: Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytosine; Drug Resistance, Multiple, Viral; Foscarnet; Ganciclovir; Genotype; Guanine; Mutation; Organophosphonates | 2014 |
Intravitreal foscarnet for recurring CMV retinitis in a congenitally infected premature infant.
Topics: Antiviral Agents; Cytomegalovirus Retinitis; Female; Foscarnet; Ganciclovir; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Infusions, Intravenous; Intravitreal Injections; Recurrence; Retinopathy of Prematurity | 2014 |
UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mutation; Organophosphonates; Viral Proteins | 2014 |
Human herpesvirus 6 encephalitis simulating brain metastases in a patient with advanced small-cell lung cancer.
Topics: Antiviral Agents; Brain Neoplasms; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Immunocompromised Host; Lung Neoplasms; Male; Middle Aged; Roseolovirus Infections; Small Cell Lung Carcinoma | 2013 |
Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; High-Throughput Nucleotide Sequencing; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Organophosphonates; Pneumonia, Viral; Time Factors; Viral Proteins; Virus Replication | 2014 |
Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient.
Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Leflunomide; Lung Transplantation; Monitoring, Immunologic; Transplant Recipients | 2014 |
Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.
Topics: Acyclovir; Amino Acid Sequence; Animals; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cytarabine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Guanine; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Molecular Sequence Data; Protein Kinases; Rhadinovirus; Sequence Alignment; Structure-Activity Relationship; Thymidine Kinase; Viral Proteins | 2014 |
Cytomegalovirus retinitis in HIV-negative patients: a practical management approach.
Topics: Adult; Aged; Antigens, Viral; Antiviral Agents; Child, Preschool; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Seronegativity; Humans; Immediate-Early Proteins; Infant; Injections, Intravenous; Intravitreal Injections; Male; Polymerase Chain Reaction; Retrospective Studies; Viral Load; Visual Acuity | 2015 |
Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
Topics: Acyclovir; Analysis of Variance; Animals; Antiviral Agents; Chlorocebus aethiops; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Gene Transfer Techniques; Herpesvirus 1, Human; Humans; Kinetics; Models, Molecular; Mutation, Missense; Protein Structure, Secondary; Vero Cells | 2015 |
Perivascular hypofluorescence in frosted branch angiitis.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Female; Fluorescein Angiography; Foscarnet; Ganciclovir; Humans; Intravitreal Injections; Middle Aged; Retinal Vasculitis; Valganciclovir | 2015 |
Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis.
Topics: Antiviral Agents; Chromosomes, Artificial, Bacterial; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Models, Molecular; Mutagenesis; Organophosphonates; Phenotype; Point Mutation; Protein Domains; Viral Proteins | 2016 |
Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
Topics: Adult; Allografts; Antiviral Agents; Biopsy; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Immunohistochemistry; Immunosuppressive Agents; Kidney Transplantation; Time Factors; Treatment Outcome | 2016 |
Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antiviral Agents; Cohort Studies; Communicable Diseases; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Organ Transplantation; Retrospective Studies; Risk Factors; Valganciclovir; Young Adult | 2016 |
Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Gene Expression; Humans; Microbial Sensitivity Tests; Mutation; Organophosphonates; Protein Domains; Viral Proteins | 2016 |
Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance.
Topics: Adolescent; Adult; Antiviral Agents; Child; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Immunocompromised Host; Infant; Middle Aged; Mutation; Organophosphonates; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Polymorphism, Genetic; Viral Proteins | 2016 |
Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation.
Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intestines; Isoxazoles; Leflunomide; Male; Middle Aged; Retrospective Studies; Viremia | 2016 |
Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients.
Topics: Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; High-Throughput Nucleotide Sequencing; Humans; Kidney Transplantation; Male; Middle Aged; Mutation; Phylogeny; Retrospective Studies; Sequence Analysis, DNA; Viral Load | 2016 |
Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Liver Transplantation; Meningoencephalitis; Middle Aged; Polymerase Chain Reaction; Renal Dialysis | 2016 |
Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection.
Topics: Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Lung Transplantation; Transplant Recipients; Viral Load | 2016 |
Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Transplant Recipients | 2016 |
Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series.
Topics: Aged; Antiviral Agents; Chemotherapy, Adjuvant; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Salvage Therapy; Transplant Recipients; Virus Activation | 2016 |
Dual Intravitreal Injections With Foscarnet and Ganciclovir for Ganciclovir-Resistant Recurrent Cytomegalovirus Retinitis in a Congenitally Infected Infant.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Infant; Intravitreal Injections; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Viral Load; Vitreous Body | 2016 |
Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene.
Topics: Amino Acid Substitution; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Mutation; Phenotype; Viral Proteins | 2017 |
Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Mutation; Organ Transplantation; Organophosphonates; Postoperative Complications; Real-Time Polymerase Chain Reaction; Retrospective Studies; Thailand; Young Adult | 2017 |
Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Antiviral Agents; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Registries; Retrospective Studies; Risk Factors; Roseolovirus Infections; Stem Cell Transplantation; Survival Analysis; Tissue Donors; Transplantation, Homologous | 2017 |
Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Postoperative Complications; Tissue Donors | 2017 |
Analysis of five cases of human herpesvirus-6 myelitis among 121 cord blood transplantations.
Topics: Adolescent; Adult; Aged; Allografts; Antiviral Agents; Autonomic Nervous System Diseases; Cord Blood Stem Cell Transplantation; Female; Fever; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myelitis; Pain; Pruritus; Spinal Cord; Treatment Outcome; Young Adult | 2018 |
Safety and efficacy of foscarnet for the management of ganciclovir-resistant or refractory cytomegalovirus infections: A single-center study.
Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Glomerular Filtration Rate; Humans; Male; Middle Aged; Retrospective Studies | 2018 |
Molecular detection of human herpesvirus 7 DNA in cerebrospinal fluid from adult patients with neurological disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Encephalitis, Viral; Female; Foscarnet; Ganciclovir; Herpesvirus 7, Human; Humans; Male; Meningitis, Viral; Middle Aged; Myelitis; Retrospective Studies; Roseolovirus Infections; Spinal Puncture | 2018 |
Antiviral combination therapy for cytomegalovirus infection in high-risk infants.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Infant, Newborn; Male; Retrospective Studies; Risk Factors; Severe Combined Immunodeficiency; Survival Analysis; Viral Load; Viremia | 2018 |
Antiviral therapy for the treatment of HHV-6-associated syndromes after transplant.
Topics: Antiviral Agents; Control Groups; Cord Blood Stem Cell Transplantation; Encephalitis; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Prospective Studies; Syndrome | 2019 |
In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
Topics: Antiviral Agents; Benzimidazoles; Cell Line; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Antagonism; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Endodeoxyribonucleases; Fibroblasts; Foscarnet; Ganciclovir; Guanine; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Ribonucleosides; Viral Proteins; Virus Replication | 2018 |
Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report.
Topics: Adolescent; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Kidney Transplantation; Mutation | 2018 |
Acute Retinal Necrosis: Virological Features Using Quantitative Polymerase Chain Reaction, Therapeutic Management, and Clinical Outcomes.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Aqueous Humor; Cytomegalovirus Retinitis; DNA, Viral; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster Ophthalmicus; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 3, Human; Humans; Intravitreal Injections; Male; Middle Aged; Real-Time Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Viral Load; Visual Acuity; Young Adult | 2019 |
Cost analysis of ganciclovir and foscarnet in recipients of allogeneic hematopoietic cell transplant with cytomegalovirus viremia.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chemoprevention; Child; Costs and Cost Analysis; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Health Care Costs; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Transplant Recipients; Viremia; Young Adult | 2020 |
Comparison of Transplantation Outcomes after Foscarnet and Ganciclovir Administration as First-Line Anti-Cytomegalovirus Preemptive Therapy.
Topics: Antiviral Agents; Cytomegalovirus; Foscarnet; Ganciclovir; Humans; Neoplasm Recurrence, Local; Retrospective Studies | 2021 |
Continuous-Infusion Foscarnet Facilitates Administration in Hematopoietic Stem Cell Transplantation Patients.
Topics: Cytomegalovirus Infections; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies | 2021 |
Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Quinazolines; Transplant Recipients; Valganciclovir | 2021 |
Cutaneous presentation of disseminated cytomegalovirus infection in a non-transplant patient with hematological malignancy: A case report.
Topics: Antiviral Agents; Cytomegalovirus Infections; Fatal Outcome; Foscarnet; Ganciclovir; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Skin Diseases | 2022 |
Intra-host diversity of drug-resistant cytomegalovirus: A case report of cytomegalovirus infection after allogeneic hematopoietic cell transplantation.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Mutation; Phosphotransferases (Alcohol Group Acceptor) | 2022 |
Artificial stem cells mediated inflammation-tropic delivery of antiviral drugs for pneumonia treatment.
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Fatty Acids, Monounsaturated; Foscarnet; Ganciclovir; Humans; Inflammation; Nanoparticle Drug Delivery System; Pneumonia; Polylactic Acid-Polyglycolic Acid Copolymer; Quaternary Ammonium Compounds; Stem Cells | 2022 |
Efficacy of ganciclovir versus foscarnet in ganciclovir-resistant cytomegalovirus retinitis: A case report.
Topics: Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Male; Middle Aged; Treatment Outcome | 2023 |
[Resistance to antiviral drugs in human viruses from the subfamily
Topics: Antiviral Agents; Betaherpesvirinae; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans | 2022 |
Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients.
Topics: Antiviral Agents; Benzimidazoles; Cidofovir; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Prevalence; Transplant Recipients; Viral Proteins | 2023 |